Spectrum Requirements for Advanced Medical Technologies, 22696-22710 [E9-11063]
Download as PDF
22696
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
environmental standard intended to
mitigate health or safety risks.
H. Executive Order 13211—Actions
Concerning Regulations That
Significantly Affect Energy Supply,
Distribution, or Use
This final action is not subject to
Executive Order 13211 (66 FR 28355,
May 22, 2001) because it is not a
significant regulatory action under
Executive Order 12866.
I. National Technology Transfer and
Advancement Act
Section 12(d) of the National
Technology Transfer and Advancement
Act of 1995 (NTTAA), Public Law 104–
113, 12(d) (15 U.S.C. 272 note), directs
EPA to use voluntary consensus
standards in its regulatory activities
unless to do so would be inconsistent
with applicable law or otherwise
impractical. Voluntary consensus
standards are technical standards (for
example, materials specifications, test
methods, sampling procedures, and
business practices) that are developed or
adopted by voluntary consensus
standards bodies. The NTTAA directs
EPA to provide Congress, through OMB,
explanations when the Agency decides
not to use available and applicable
voluntary consensus standards.
This final action does not involve
technical standards; therefore, EPA did
not consider the use of any voluntary
consensus standards.
jlentini on PROD1PC65 with RULES
J. Executive Order 12898—Federal
Actions To Address Environmental
Justice in Minority Populations and
Low-Income Populations
Executive Order 12898 (59 FR 7629,
February 16, 1994) establishes Federal
executive policy on environmental
justice. Its main provision directs
Federal agencies, to the greatest extent
practicable and permitted by law, to
make environmental justice part of their
mission by identifying and addressing,
as appropriate, disproportionately high
and adverse human health or
environmental effects of their programs,
policies, and activities on minority
populations and low-income
populations in the United States.
EPA has determined that this final
action will not have disproportionately
high and adverse human health or
environmental effects on minority or
low-income populations because it does
not affect the level of protection
provided to human health or the
environment. Therefore, Executive
Order 12898 does not apply to this final
action.
VerDate Nov<24>2008
18:53 May 13, 2009
Jkt 217001
K. Congressional Review Act
The Congressional Review Act, 5
U.S.C. 801 et seq., as added by the Small
Business Regulatory Enforcement
Fairness Act of 1996, generally provides
that before a rule may take effect, the
agency promulgating the rule must
submit a rule report, which includes a
copy of the rule, to each House of the
Congress and to the Comptroller General
of the United States. EPA submitted a
report containing this rule and other
required information to the U.S. Senate,
the U.S. House of Representatives, and
the Comptroller General of the United
States prior to publication of the rule in
the Federal Register. A major rule
cannot take effect until 60 days after it
is published in the Federal Register.
This final action is not a ‘‘major rule’’
as defined by 5 U.S.C. 804(2). Therefore,
this final action will be effective on May
14, 2009.
L. Judicial Review
Under CAA section 307(b), judicial
review of this final action is available
only by filing a petition for review in
the U.S. Court of Appeals for the District
of Columbia Circuit on or before July 13,
2009. Under CAA section 307(d)(7)(B),
only those objections to the final rule
that were raised with specificity during
the period of public comment may be
raised during judicial review. Moreover,
under CAA section 307(b)(2), the
requirements established by this final
rule may not be challenged separately in
any civil or criminal proceedings
brought by EPA to enforce these
requirements.
VI. Statutory Authority
The statutory authority for this action
is provided by sections 307(d)(7)(B),
101, 111, 114, 116, and 301 of the CAA
as amended (42 U.S.C. 7401, 7411, 7414,
7416, and 7601). This notice is also
subject to section 307(d) of the CAA (42
U.S.C. 7407(d)).
List of Subjects
40 CFR Part 51
Environmental protection,
Administrative practice and procedure,
Air pollution control, Baseline
emissions, Intergovernmental relations,
Aggregation, Major modifications,
Reporting and recordkeeping
requirements.
40 CFR Part 52
Environmental protection,
Administrative practice and procedure,
Air pollution control, Baseline
emissions, Incorporation by reference,
Intergovernmental relations,
Aggregation, Major modifications,
PO 00000
Frm 00058
Fmt 4700
Sfmt 4700
Reporting and recordkeeping
requirements.
Dated: May 8, 2009.
Lisa P. Jackson,
Administrator.
[FR Doc. E9–11271 Filed 5–13–09; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL COMMUNICATIONS
COMMISSION
47 CFR Parts 1, 2 and 95
[ET Docket Nos. 06–135, 05–213 and 03–
92, RM–11271; FCC 09–23]
Spectrum Requirements for Advanced
Medical Technologies
AGENCY: Federal Communications
Commission.
ACTION: Final rule.
SUMMARY: This document establishes a
new Medical Device
Radiocommunication Service
(MedRadio Service) of the Commission’s
rules. This new service incorporates the
existing Medical Implant
Communications Service (MICS) ‘‘core’’
band at 402–405 MHz, and also includes
two megahertz of newly designated
spectrum in the adjacent ‘‘wing’’ bands
at 401–402 MHz and 405–406 MHz. The
MedRadio Service will accommodate
the operation of body-worn as well as
implanted medical devices, including
those using either listen-before-talk
(‘‘LBT’’) frequency monitoring or nonLBT spectrum access methods, in
designated portions of the 401–406 MHz
band.
DATES: Effective August 12, 2009.
FOR FURTHER INFORMATION CONTACT: Gary
Thayer, (202) 418–2290, e-mail
Gary.Thayer@fcc.gov.
This is a
summary of the Commission’s Report
and Order, ET Docket Nos. 06–135, 05–
213, and 03–92, RM–11271, FCC 09–23,
adopted March 19, 2009, and released
March 20, 2009. The full text of this
document is available on the
Commission’s Internet site at https://
www.fcc.gov. It is also available for
inspection and copying during regular
business hours in the FCC Reference
Center (Room CY–A257), 445 12th St.,
SW., Washington, DC 20554. The full
text of this document also may be
purchased from the Commission’s
duplication contractor, Best Copy and
Printing Inc., Portals II, 445 12th St.,
SW., Room CY–B402, Washington, DC
20554; telephone (202) 488–5300; fax
(202) 488–5563; e-mail
FCC@BCPIWEB.COM.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\14MYR1.SGM
14MYR1
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
jlentini on PROD1PC65 with RULES
Summary of the Report and Order
1. Overview. In July 2006, the
Commission adopted a Notice of
Proposed Rulemaking (NPRM), Notice
of Inquiry (NOI) and Order—
collectively, the MedRadio NPRM. In
the MedRadio NPRM, the Commission
proposed to establish a new service for
medical radiocommunication devices to
better accommodate the varieties of new
implantable and body-worn medical
devices.
2. In this Report and Order, the
Commission decided to establish a new
Medical Device Radio-communication
Service (MedRadio Service) under part
95 of the Commission’s rules. Under the
rules adopted by the Commission in this
Report and Order, this new service
incorporates the existing Medical
Implant Communications Service
(MICS) ‘‘core’’ band at 402–405 MHz,
and also includes two megahertz of
newly designated spectrum in the
adjacent ‘‘wing’’ bands at 401–402 MHz
and 405–406 MHz. Thus, the MedRadio
Service will provide a total of five
megahertz of contiguous spectrum on a
secondary basis and non-interference
basis for advanced wireless medical
radiocommunication devices used for
diagnostic and therapeutic purposes in
humans. In addition, the MedRadio
Service will accommodate the operation
of body-worn as well as implanted
medical devices, including those using
either listen-before-talk (‘‘LBT’’)
frequency monitoring or non-LBT
spectrum access methods, in designated
portions of the 401–406 MHz band.
3. The Commission found that the
new MedRadio spectrum in the 401–402
MHz and 405–406 MHz wing bands is
well suited for use on a secondary basis
by the medical implant and body-worn
devices covered by this Order for
several reasons. First, these frequencies
offer the same propagation, availability,
and compatibility characteristics that
were found to be favorable for the MICS
in the 402–405 MHz core band. In
addition, this new designation will
result in a continuous span of spectrum
(from 401–406 MHz) that matches the
five-megahertz of spectrum that is also
designated internationally for similar
use by medical implant and body-worn
devices.
4. The Commission noted that the
service and technical rules adopted in
this Report and Order for the MedRadio
Service are based upon the existing
MICS rules, and include modified
spectrum sharing requirements in the
new wing bands. The new rules will
permit the use of both medical implant
devices and medical body-worn devices
VerDate Nov<24>2008
18:53 May 13, 2009
Jkt 217001
in specified segments of the 401–406
MHz band.
5. The Commission found that these
new MedRadio sharing rules will
provide a greater degree of flexibility
than is permitted by the existing
medical implant rules, while also
assuring spectrum use compatibility
among different device types. The
Commission further found that the new
designation in the wing bands will
provide the additional shared spectrum
that is urgently needed for operation of
both implant and body-worn devices.
The Commission stated its further belief
that the MedRadio rules adopted in this
Order should encourage the continuing
use of the legacy MICS core band
predominantly for life-critical
applications, such as those served by
the existing population of medical
implant devices presently used.
6. With respect to the potential for
interference to incumbent users of the
401–402 MHz and 405–406 MHz wing
bands arising from the operation of
MedRadio devices, the Commission
concluded that the potential for such
interference is negligibly small. The
Commission noted that, in the United
States, the 401–406 MHz band is
allocated for various Federal and nonFederal uses on a primary basis, and the
402–405 MHz band is allocated for
mobile, except mobile aeronautical,
service on a secondary basis, with use
limited to MICS. The Commission
determined that, given the ultra low
power limits and intermittent operating
modes that will be used by these
medical devices, and the expectation of
large separation distances, there is little
likelihood that these medical devices
could cause harmful interference to
incumbent operations.
7. With respect to the potential for
harmful effects to MedRadio devices
due to received interference from
incumbent users, the Commission
observed that it would be beneficial if
MedRadio devices employed robust
designs. For example, the Commission
noted that MedRadio medical devices—
particularly those devices used for life
critical and time-sensitive
applications—might need to employ a
variety of error detection and correction
techniques, frequency monitoring
capabilities, and re-transmission
protocols.
8. In broader terms, the Commission
determined that the additional spectrum
and enhanced flexibility afforded in the
new rules will promote the accelerated
development of newer generations of
advanced medical device technologies.
These advances, the Commission found,
will herald dramatic improvements in
therapeutic/diagnostic patient care and
PO 00000
Frm 00059
Fmt 4700
Sfmt 4700
22697
quality of life for countless individuals.
The Commission also noted that the
MedRadio designation and rules
adopted in this Order are harmonized
for the most part in their general
approach with similar European
Telecommunication Standards Institute
(ETSI) standards relating to use of the
401–406 MHz band by medical implant
and body-worn devices in other regions
of the world. The Commission stated its
belief that such harmonization will
serve the public interest by offering
Americans greater confidence of reliable
device operation while traveling abroad,
and conversely, by offering similar
confidence for foreign visitors to the
United States. The Commission also
determined that economies of scale
resulting from harmonized rules for
domestic manufacturers seeking to
compete in the world market should
foster a reduction of device prices, thus
making the benefits of such technologies
more widely available and affordable for
the American public.
9. Licensing. Consistent with the
existing MICS licensing scheme, the
Commission decided that the new
MedRadio service at 401–406 MHz will
be governed under Part 95 of the
Commission’s rules, thus providing for
license-by-rule operation throughout the
5 megahertz band. The Commission
concluded that this approach minimizes
regulatory procedures and will facilitate
the more expeditious deployment of
new generations of beneficial wireless
medical devices in these bands that can
improve the quality of life for countless
Americans, thus serving the public
interest, convenience and necessity. The
Commission also decided that the
operation of medical devices in the
MedRadio band will be on a secondary,
non-interference basis with respect to
other authorized services and as such
they must accept harmful interference
from the systems operating in those
services. MedRadio devices will operate
on a shared, non-exclusive basis with
respect to each other.
10. Definitions—Implant and Bodyworn Devices. In order to be deemed a
medical body-worn device or medical
body-worn transmitter, the Commission
required that the antenna of the
associated patient-worn device be
placed upon or in very close proximity
(e.g., within a few centimeters) to the
body. In order to be classified as a
medical implant transmitter or medical
implant device, the Commission
required that the transmitting antenna of
the patient device must itself be
implanted wholly within the body—
which would include any point below
the skin, or more deeply within the
body. The Commission retained the
E:\FR\FM\14MYR1.SGM
14MYR1
jlentini on PROD1PC65 with RULES
22698
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
existing definitions for medical implant
devices.
11. Authorized Frequencies for
Implant and Body-Worn Devices. The
Commission concluded that implanted
devices will be permitted in both the
existing MICS core band at 402–405
MHz, as well as in the wing bands at
401–402 MHz and 405–406 MHz. This
will allow medical implant devices to
operate anywhere in the 401–406 MHz
band—but subject to different technical
requirements in the core and wing
bands.
12. The Commission decided, with
one exception, to permit body-worn
devices to operate only in the wing
bands at 401–402 MHz and 405–406
MHz. Thus, in the new MedRadio wing
bands, both implant and body-worn
devices will be allowed to operate—
under common technical requirements
for each—throughout both the 401–402
MHz and 405–406 MHz frequency
range. The Commission stated its belief
this approach will serve to
accommodate a greater variety of
implant and body-worn devices. The
Commission also observed that, by
preserving the core band at 402–405
MHz primarily for communications
involving deeply implanted devices,
these frequencies would likely continue
to be used largely for life-critical
medical devices such as cardiac
defibrillators.
13. As an exception to the general rule
for body-worn devices, the Commission
decided to permit the operation in the
core band of temporary body-worn
devices that are used to evaluate the
efficacy of an implanted medical device.
14. The Commission determined that
allowing the operation of such
temporary body-worn devices will
enhance the therapeutic and diagnostic
options available to patients. In
particular, the Commission noted that
this will allow physicians to better
evaluate the efficacy of proposed
treatments involving implanted devices
prior to actual device implantation. The
Commission decided to permit the
operation of such temporary body-worn
devices on any frequency in the 402–
405 MHz core band provided that: (1)
Such external operation is limited solely
to evaluating with a patient the efficacy
of a fully implanted permanent medical
device that is intended to replace the
temporary body-worn device; (2) RF
transmissions from the external device
must cease following the patient
evaluation period, which may not
exceed 30 days, except where a health
care practitioner determines that
additional time is necessary due to
unforeseen circumstances; (3) the
maximum output power of the external,
VerDate Nov<24>2008
18:53 May 13, 2009
Jkt 217001
temporary body-worn device shall not
exceed 200 nW EIRP; and (4) the
external device must comply fully with
all other MedRadio rules described
throughout the core 402–405 MHz band.
15. The Commission declined to
explicitly limit the core band to lifecritical and time-sensitive applications,
or to designate the wing bands for nonlife-critical, non-time sensitive
applications. The Commission said that
its decision to limit the core band
primarily to communications involving
implanted devices, coupled with the
technical rules adopted for use of the
core and wing bands will achieve much
the same result, while providing greater
flexibility for device manufacturers and
practitioners. The Commission
determined that leaving the ultimate
decision on these matters to health care
professionals and medical device
manufactures, in concert with FDArequired risk management processes,
would result in better and more flexible
use of this scarce spectrum resource.
16. Permissible Communications and
Operator Eligibility. The Commission
concluded that the new MedRadio
service will be governed by the same
operator eligibility and permissible
communications requirements that
pertain to the legacy MICS. According to
the Commission, this will result in a
more beneficial use of the spectrum
than alternative approaches.
17. More specifically, the Commission
decided that MedRadio devices may be
used only by persons for diagnostic and
therapeutic purposes, and only when
provided for such purposes to a human
patient under the direction of a duly
authorized health care professional.
Furthermore, the Commission limited
the MedRadio service to the
transmission of non-voice data.
MedRadio programmer/control
transmitters may not relay information
on MedRadio frequencies to a receiver
that is not included with a MedRadio
device. The Commission concluded that
these requirements are central to
maintaining the originally intended
character and utility of this spectrum,
which the Commission found has
proven to be of significant benefit to
many patients over the years.
18. The Commission declined to
adopt rules in this Order that would
permit the operation of wireless hearing
aids in the upper portion of the lower
MedRadio wing band. However, in
recognition of the important public
interest benefits associated with this
proposal, the Commission welcomed
additional technical submissions or
revisions to address whether this or
some other band(s) could accommodate
various types of hearing aid devices,
PO 00000
Frm 00060
Fmt 4700
Sfmt 4700
and stated that it would consider
developing a record through a notice of
proposed rulemaking to more fully
analyze these matters.
19. The Commission also declined to
allow the use of MedRadio devices in
connection with animal test subjects in
the course of human drug research. The
Commission found that such testing
would not, in and of itself, directly
perform any diagnostic or therapeutic
function for a human patient. In
contrast, the Commission observed that,
since its creation, the legacy MICS had
been explicitly reserved for use by
devices performing diagnostic and
therapeutic functions with human
patients and only when such use has
been duly authorized by a health care
professional. It further found that
changing the eligibility requirements to
permit animal test subject use would
constitute a major departure from these
underlying requirements and that such
a departure did not appear to be
warranted based upon the record in this
proceeding. From a procedural
perspective, the Commission further
stated that the MedRadio NPRM neither
proposed, nor sought comment on,
modifying these basic service and
eligibility provisions; and that it
particularly did not address the specific
question at issue here of whether use of
the MICS/MedRadio frequencies should
be extended to animal testing. Thus, the
Commission concluded that it had an
insufficient substantive record or
procedural notice upon which to pursue
the matter of animal test subjects.
20. MedRadio channels. The
Commission decided to generally carry
forward the MICS rules into the new
MedRadio Service. Under the existing
rules, no particular channeling scheme
is specified for the operation of MICS
devices. Instead, a ‘‘channel’’ is simply
defined as any continuous segment of
spectrum used by a medical device.
Thus, a MedRadio device may transmit
on any center frequency so long as the
maximum authorized emission
bandwidth is not exceeded. The
Commission stated its belief that this
approach is beneficial because it would
continue to provide the greater
flexibility that device manufacturers
now use as compared with a rigid
channeling scheme.
21. Emission Bandwidth. With respect
to the new MedRadio wing bands at
401–402 MHz and 405–406 MHz, the
Commission concluded that a 100
kilohertz maximum authorized emission
bandwidth in the limited space of the
one-megahertz wide wing bands will
foster more intensive spectrum
utilization by a greater number of
devices as compared with a 300
E:\FR\FM\14MYR1.SGM
14MYR1
jlentini on PROD1PC65 with RULES
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
kilohertz maximum bandwidth. The
Commission determined that this
smaller bandwidth would allow more
devices to use the wing bands on nonoverlapping spectrum. In addition, the
Commission found that this bandwidth
will also serve to minimize interference
potential from other MedRadio devices,
particularly in light of the fact that both
LBT and non-LBT devices will share the
entire wing bands.
22. As one exception to the general
bandwidth requirement for the wing
bands, the Commission decided to allow
up to a 150 kilohertz maximum
authorized emission bandwidth at
401.85–402 MHz. In reaching this
decision, the Commission recognized
that some body worn devices, such as
the glucose monitoring devices that are
now operating in the core band under a
waiver, need a slightly wider emission
bandwidth. Thus, the Commission
found that its decision here to allow a
slightly wider emission bandwidth at
the upper edge of the 401–402 MHz
wing band will facilitate transitioning
such devices now operating under rule
waivers out of the core band. In
addition, the Commission observed that
the narrower bandwidth for the wing
bands, is expected to be better suited for
non-life-critical devices—namely, those
with less severe battery life constraints
that are tailored for operation with
lower bandwidth data streams utilizing
a relatively greater number of longer
data transmission sessions as compared
with devices used in the core band.
23. For the core band at 402–405
MHz, the Commission decided to
maintain the existing maximum
authorized emission bandwidth of 300
kilohertz. The Commission found that,
relative to the 100 kilohertz bandwidth
it adopted for the wing bands, this 300
kilohertz bandwidth will better facilitate
more data-intensive transmissions of
shorter duration which tend to be more
energy efficient, and thus prolong
battery life for implants. This will also
support higher data transmission rates
than could be accommodated by the
maximum authorized emission
bandwidth of 100 kilohertz channels of
the wing bands, and thus may be more
desirable for certain applications. The
Commission found that such
characteristics are especially beneficial
in extending the battery life of deep
implant devices.
24. The Commission decided that it
would continue to permit MedRadio
transmitters to utilize full duplex or half
duplex communications if the total
amount of bandwidth used by all of the
MedRadio channels employed by a
MedRadio device during a MedRadio
communications session does not
VerDate Nov<24>2008
18:53 May 13, 2009
Jkt 217001
exceed the maximum authorized
emission bandwidth (i.e., 100 kilohertz
in the wing bands and 300 kilohertz in
the core band). Moreover, smaller
bandwidths may be employed by a
single MedRadio device so long as the
device adheres to all other EIRP and
unwanted emission limits. For example,
a single MedRadio device operating in
the wing bands could be designed to
operate nominally on two channels,
each having a maximum emission
bandwidth of 50 kilohertz, because the
communications session would, in
aggregate, be 100 kilohertz. The
Commission noted that, in essence,
these provisions carry forward the
existing channel use provisions of the
MICS rules into the new MedRadio
rules.
25. Frequency monitoring
requirement. In the Report and Order,
the Commission observed the current
MICS rules require that the
programmer/control transmitter
associated with a medical implant
device in the 402–405 MHz band must
incorporate a frequency monitoring
mechanism to monitor the channel or
channels that the medical device
transmitters intend to occupy. The
Commission further stated its belief that
an LBT frequency monitoring
requirement is beneficial because it
facilitates spectrum sharing among
many uncoordinated devices and can
reduce the likelihood of harmful
interference from federal systems that
are allocated on a primary basis. Thus,
the Commission decided to maintain the
current frequency monitoring protocol
specified in the form MICS rules as a
general requirement for implant devices
permitted throughout the entire 401–
406 MHz MedRadio core band, as well
as for body-worn devices permitted in
the new wing bands. In addition, the
Commission also extended the ‘‘medical
implant event’’ exception of the current
rules to LBT-enabled implant devices
operating throughout the 401–406 MHz
MedRadio band.
26. In further recognition of the
potential advantages of non-LBT
spectrum access methods for certain low
power, low duty cycle (LP–LDC)
devices—particularly, in terms of
extended battery life, reduced
complexity, and lower device cost to
patients—the Commission decided to
permit the use of non-LBT spectrum
access methods in the wing bands, with
certain transmitter power and duty
cycle limits, by both implant and bodyworn devices. In addition, the
Commission permitted the use of nonLBT spectrum access methods for
implant devices that operate with an
emission bandwidth not exceeding 300
PO 00000
Frm 00061
Fmt 4700
Sfmt 4700
22699
kilohertz centered at 403.65 MHz in the
existing core band with certain
transmitter power and duty cycle limits.
Finally, the Commission also decided to
permit the operation on any of the
frequencies in the 402–405 MHz band of
temporary body-worn transmitting
devices that are used solely during a
limited patient evaluation period in
order to determine the suitability of a
fully implanted device, provided that
they fully comply with all other
MedRadio rules applicable to the band.
27. Transmitter power and duty cycle.
The Commission limited the maximum
EIRP of LBT-enabled implant devices
throughout the 401–406 MHz band and
LBT-enabled body-worn medical
devices in the wing bands to 25
microwatts EIRP. The Commission
determined that, as with the original
MICS rules, this limit is intended to
ensure efficient spectrum sharing and
compatibility among multiple
uncoordinated devices. Furthermore,
the 25 microwatt limit will maintain
continuity with the present EIRP limit
and LBT frequency monitoring
requirement for the core band (which
we also maintain under the new
MedRadio rules) that has served well for
spectrum access.
28. With respect to access to the 402–
405 MHz band by non-LBT devices, the
Commission found that the convergence
of comments in the record, particularly
subsequent to the adoption by ETSI of
similar standards, supported permitting
operation by such devices with a total
emission bandwidth not exceeding 300
kilohertz, centered at 403.65 MHz, with
a maximum EIRP of 100 nanowatts and
with maximum duty-cycle and
transmission session limits of 0.01%
and ten per hour, respectively. The
Commission stated that its decision was
informed by the increasingly
widespread adoption of standards
internationally that provide for non-LBT
spectrum access methods in the 402–
405 MHz band. Furthermore, based
upon the Commission’s prior experience
with single-channel non-LBT devices
operating under rule waivers in the core
MICS band the Commission concluded
that these EIRP and duty cycle limits
would be sufficiently conservative to
permit efficient spectrum sharing
between LBT enabled and non-LBT
devices that choose to operate at 403.65
MHz.
29. For devices using non-LBT
spectrum access methods in the new
MedRadio wing bands at 401–402 and
405–406 MHz, the Commission adopted
power and duty cycle limits that match
the proposals in the MedRadio NPRM,
namely a maximum EIRP of 250
nanowatts, together with a maximum
E:\FR\FM\14MYR1.SGM
14MYR1
jlentini on PROD1PC65 with RULES
22700
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
duty cycle limit of 0.1% and a
maximum limit of 100 communication
sessions per hour. The Commission
stated its belief that permitting the
higher EIRP of 250 nanowatts for nonLBT operation in the wing bands, as
compared with the 100 nanowatts
adopted for non-LBT operation in the
core band, will serve to encourage use
of the wing bands for the majority of
non-LBT applications.
30. The Commission also recognized
that some body worn devices may
require higher power and greater
bandwidth, such as the glucose
monitoring devices manufactured by
one manufacturer that are now
operating in the core band under a
waiver. Thus, the Commission decided
to also allow non-LBT MedRadio
devices using a maximum of 25
microwatts EIRP to operate at 401.85–
402 MHz at the upper end of the lower
wing band. The Commission
determined that its decision would
facilitate the transition of such devices
now operating under waivers out of the
core band, and into the new MedRadio
wing bands. The Commission also noted
that permitting the higher power and
bandwidth would also provide
flexibility for other manufacturers
designing medical devices in these
bands.
31. Unwanted emissions. The
Commission retained without
modification the existing in-band and
out-of-band emission limits for the
MedRadio core band frequencies at 402–
405 MHz. For the new MedRadio wing
bands at 401–402 MHz and 405–406
MHz, the Commission adopted an
emission mask having the same form as
the emission mask that already exists for
the core band, but modified to apply
over the narrower 100 kilohertz
maximum authorized emission
bandwidth of the wing band. Thus, the
Commission required that emissions
from devices operating within the
MedRadio wing bands more than 50
kilohertz away from the center
frequency of a transmission be
attenuated below the actual transmitter
output power by at least 20 dB. In
addition, it required emissions 100
kilohertz or less below 401 MHz, or
above 406 MHz, to be attenuated below
the maximum permitted output power
by at least 20 dB. Finally, for out-ofband emissions at more than 100
kilohertz outside the 401 MHz and 406
MHz MedRadio band edges, the
Commission adopted generally the same
field strength limits on emissions that
presently apply to the core band.
32. The Commission declined to
impose more restrictive limits on
emissions from MedRadio wing band
VerDate Nov<24>2008
18:53 May 13, 2009
Jkt 217001
devices into the existing core band. The
Commission said that under such an
approach, which was recommended by
one commenter, wing band devices
would be burdened with more stringent
limits on radiation into the core band as
compared to core band devices. The
Commission found no compelling
reason to place wing band devices on
such an unequal footing with core band
devices, particularly if such a limit were
to be set below the existing general
emission limits contained in § 15.209 as
suggested by one commenter. The
Commission stated that it was confident
that manufacturers of wing band devices
are capable of designing their products
to be compatible with and to protect
core band devices, especially when both
types of devices are used by the same
patient. In addition, the Commission
found that the emission limits it
adopted would afford sufficient
protection to satellite operations on
frequencies below 401 MHz adjacent to
the lower MedRadio wing band.
33. RF safety and EIRP compliance.
The Commission retained the basic
requirements in the current rules as they
apply RF safety and EIRP compliance
requirements for implanted devices. In
addition, the Commission decided that,
to the extent feasible, body-worn
MedRadio devices shall be governed by
the same requirements as other handheld transmitting devices for the
purposes of demonstrating compliance
with RF safety and EIRP limits.
34. The Commission observed that it
has another ongoing proceeding
concerning RF exposure that would be
better suited to address several other
concerns expressed by some
commenters. One issue involves
whether and when open-area test sites
or body-torso simulator measurements
should be performed, and whether a 4
dB EIRP correction factor should be
applied between implant and bodyworn devices to account for the
absorption of radio energy by body
tissue that can be associated with
implanted devices. A second issue
involves whether unspecified ‘‘other
techniques’’ (beyond the finite
difference time domain (FDTD)
technique cited in the existing rules)
could be used for equipment
authorization and RF exposure
evaluation purposes. In view of the
ongoing RF safety proceeding, the
Commission declined to make any
further modifications in this Report and
Order.
35. Disposition of Biotronik and
DexCom Waivers. The Commission
noted that it had previously granted
waivers to two device manufacturers
(Biotronik and DexCom) that permit the
PO 00000
Frm 00062
Fmt 4700
Sfmt 4700
manufacture and marketing in the
United States of certain models of
cardiac and diabetic therapy devices
that do not possess the LBT frequency
monitoring capability required by the
present MICS rules for the core band at
402–405 MHz. Both waivers were stated
to be valid for one year from the
effective date of the final MedRadio
rules adopted in this proceeding.
36. With respect to the Biotronik
Waiver, the Commission found that the
technical parameters of the authorized
cardiac devices would now be
encompassed within the provisions of
the new MedRadio rules adopted
herein—which provide for non-LBT
operation by low power, low duty cycle
implants operating between 403.5–403.8
MHz in the 402–405 MHz core band.
Consequently, the Commission found
that Biotronik Waiver would be
rendered moot upon the effective date of
the MedRadio rules adopted in this
Report and Order.
37. With respect to the DexCom
Waiver, the Commission found that the
covered devices did not comply with
the new MedRadio rules. It thus decided
to extend the waiver term for four years
from the effective date of the MedRadio
rules adopted herein. The Commission
stated that this extended term should
provide DexCom with sufficient time to
come into compliance with the new
MedRadio rules and to obtain the
required FDA approval. The
Commission also found that continued
operation of the DexCom non-LBT
devices in the core band, particularly at
the higher power levels they use, could
in the long term prove problematic for
other rules-compliant devices—
especially those used for life-critical
applications—as the numbers of these
types of devices grow. Further, the
Commission also observed that the wing
bands provide adequate spectrum for
both LBT and non-LBT body-worn
devices and that DexCom’s devices may
reasonably be accommodated under the
new MedRadio rules for these bands. In
declining to extend the waiver for 5
years as requested by DexCom, the
Commission stated that it was not
persuaded that the relatively small
move in operating frequency, while
maintaining emission bandwidth, power
and duty cycle specifications, would
require 5 additional years. Thus, the
Commission encouraged DexCom to
transition to the newly designated
spectrum as soon as practicable.
E:\FR\FM\14MYR1.SGM
14MYR1
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
Final Regulatory Flexibility Analysis
38. As required by the Regulatory
Flexibility Act (RFA),1 an Initial
Regulatory Flexibility Analysis (IFRA)
was incorporated in the Notice of
Proposed Rulemaking and Notice of
Inquiry and Order (MedRadio NPRM) in
ET Docket No. 06–135.2 The
Commission sought written public
comment on the proposals in the
MedRadio NPRM, including comment
on the IRFA. This present Final
Regulatory Flexibility Analysis (FRFA)
conforms to the RFA.
jlentini on PROD1PC65 with RULES
A. Need for and Objectives, of the
Report and Order
39. The Report and Order establishes
the Medical Device
Radiocommunication Service
(MedRadio) under part 95 of the
Commission’s rules. This new service
will incorporate the existing Medical
Implant Communications Service
(MICS) ‘‘core’’ band at 402–405 MHz,
and include two megahertz of newly
designated spectrum in the adjacent
‘‘wing’’ bands at 401–402 MHz and 405–
406 MHz. Altogether, the MedRadio
Service will provide a total of five
megahertz of contiguous spectrum for
advanced wireless medical
radiocommunication devices to be used
for diagnostic and therapeutic purposes
in humans. Among other benefits, the
MedRadio Service will accommodate
the operation of body-worn as well as
implanted medical devices, including
those using either LBT or non-LBT
spectrum access methods, in designated
portions of the 401–406 MHz band.
40. Significant advances in wireless
implanted and body-worn medical
technologies are revolutionizing
treatment for a wide variety of medical
conditions and, even more
fundamentally, creating new health care
models serving to improve quality of life
for all Americans. As demonstrated by
the comment record in this proceeding,
implanted and body-worn medical
devices that rely upon wireless
1 See 5 U.S.C. 603. The RFA, see 5 U.S.C. 601–
612, has been amended by the Small Business
Regulatory Enforcement Fairness Act of 1966
(SBREFA), Public Law 104–121, Title II, 110 Stat.
857 (1996).
2 Investigation of the Spectrum Requirements for
Advanced Medical Technologies, Amendment of
Parts 2 and 95 of the Commission’s Rules to
Establish the Medical Device Radio
Communications Service at 401–402 and 405–406
MHz, DexCom, Inc. Request for Waiver of the
Frequency Monitoring Requirements of the Medical
Implant Communications Service Rules, Biotronik,
Inc. Request for Waiver of the Frequency
Monitoring Requirements for the Medical Implant
Communications Service Rules, ET Docket No. 06–
135, RM–11271, Notice of Proposed Rulemaking
and Notice of Inquiry and Order, 21 FCC Rcd 8164
(2006).
VerDate Nov<24>2008
18:53 May 13, 2009
Jkt 217001
technologies are being used even today
to treat a variety of cardiac and diabetic
conditions. For example, wireless
implanted cardiac devices serve as
defibrillators and pacemakers without
the need for external wired connections;
while other radio-equipped devices,
such as blood glucose monitors and
insulin pumps, support more timely
treatment for diabetic patients and allow
physicians to wirelessly retrieve data
and then make operating parameter
adjustments with greater ease and
accuracy than with the more traditional
wired connection technologies. Some
examples of newer generations of
devices that could benefit from the use
of wireless technologies include
implanted vagus nerve stimulators that
send electric pulses to the brain to treat
severe chronic depression, and deep
brain stimulators used to treat tremors
related to Parkinson’s disease.3 Such
advances have the potential to
significantly improve the quality of life
and sophistication of therapy for
countless Americans living with a
variety of medical conditions; and, in
turn, could result in lower medical costs
and extend the time between hospital
visits and surgical procedures.
B. Summary of Significant Issues Raised
by Public Comments in Response to the
IRFA
41. There were no comments filed
that specifically addressed the rules and
policies proposed in the IFRA.
C. Description and Estimate of the
Number of Small Entities to Which the
Rules Will Apply
42. The RFA directs agencies to
provide a description of and, where
feasible, an estimate of the number of
small entities that may be affected by
the proposed rules, if adopted.4 The
RFA generally defines the term ‘‘small
entity’’ as having the same meaning as
the terms ‘‘small business,’’ ‘‘small
organization,’’ and ‘‘small governmental
jurisdiction.’’ 5 In addition, the term
‘‘small business’’ has the same meaning
as the term ‘‘small business concern’’
under the Small Business Act.6 A small
business concern is one which: (1) Is
3 Id.
45
U.S.C. 603(b)(3).
U.S.C. 601(6).
6 5 U.S.C. 601(3) (incorporating by reference the
definition of ‘‘small business concern’’ in 15 U.S.C.
632). Pursuant to the RFA, the statutory definition
of a small business applies ‘‘unless an agency, after
consultation with the Office of Advocacy of the
Small Business Administration and after
opportunity for public comment, establishes one or
more definitions of such term which are
appropriate to the activities of the agency and
publishes such definition(s) in the Federal
Register.’’ 5 U.S.C. 601(3).
55
PO 00000
Frm 00063
Fmt 4700
Sfmt 4700
22701
independently owned and operated; (2)
is not dominant in its field of operation;
and (3) satisfies any additional criteria
established by the SBA.7
43. Nationwide, there are a total of
approximately 22.4 million small
businesses, according to SBA data.8 A
‘‘small organization’’ is generally ‘‘any
not-for-profit enterprise which is
independently owned and operated and
is not dominant in its field.’’ 9
Nationwide, as of 2002, there were
approximately 1.6 million small
organizations.10 The term ‘‘small
governmental jurisdiction’’ is defined
generally as ‘‘governments of cities,
towns, townships, villages, school
districts, or special districts, with a
population of less than fifty
thousand.’’ 11 Census Bureau data for
2002 indicate that there were 87,525
local governmental jurisdictions in the
United States.12 We estimate that, of this
total, 84,377 entities were ‘‘small
governmental jurisdictions.’’ 13 Thus,
we estimate that most governmental
jurisdictions are small.
44. Personal Radio Services. The
Medical Device Radio Communications
Service are being placed within part 95
of our rules (‘‘Personal Radio Services’’).
Personal radio services provide shortrange, low power radio for personal
communications, radio signaling, and
business communications not provided
for in other services. The Personal Radio
Services include spectrum licensed
under part 95 of our rules and covers a
broad range of uses.14 Many of the
licensees in these services are
individuals, and thus are not small
entities. In addition, due to the fact that
licensing of operation under part 95 is
accomplished by rule (rather than by
issuance of individual license), and due
to the shared nature of the spectrum
utilized by some of these services, the
Commission lacks direct information
other than the census data above, upon
which to base an estimation of the
number of small entities under an SBA
7 Small
Business Act, 15 U.S.C. 632 (1996).
SBA, Programs and Services, SBA Pamphlet
No. CO–0028, at page 40 (July 2002).
9 5 U.S.C. 601(4).
10 Independent Sector, The New Nonprofit
Almanac & Desk Reference (2002).
11 5 U.S.C. 601(5).
12 U.S. Census Bureau, Statistical Abstract of the
United States: 2006, Section 8, page 272, Table 415.
13 We assume that the villages, school districts,
and special districts are small, and total 48,558. See
U.S. Census Bureau, Statistical Abstract of the
United States: 2006, section 8, page 273, Table 417.
For 2002, Census Bureau data indicate that the total
number of county, municipal, and township
governments nationwide was 38,967, of which
35,819 were small. Id.
14 47 CFR part 90.
8 See
E:\FR\FM\14MYR1.SGM
14MYR1
jlentini on PROD1PC65 with RULES
22702
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
definition that might be directly affected
by the proposed rules.
45. The Commission notes, however,
that the designation for the two
megahertz of spectrum for the Medical
Device Radio Communications Service
would be limited to use by medical
implant and body-worn medical devices
and, thus, would not be shared with
other non-Federal Governmental uses.
To date, there are only a small number
of manufacturers (i.e., less than ten—as
few as five) that produce these devices,
and FDA approval must be secured
before such devices are brought to
market. Due to the stringent FDA
approval requirements, the small
number of existing medical device
manufacturers tends to focus very
narrowly on this highly specialized
market niche.
46. Wireless Communications
Equipment Manufacturers. The Census
Bureau does not have a category specific
to medical device radiocommunication
manufacturing. The appropriate
category is that for wireless
communications equipment
manufacturers. The Census Bureau
defines this category as follows: ‘‘This
industry comprises establishments
primarily engaged in manufacturing
radio and television broadcast and
wireless communications equipment.
Examples of products made by these
establishments are: transmitting and
receiving antennas, cable television
equipment, GPS equipment, pagers,
cellular phones, mobile
communications equipment, and radio
and television studio and broadcasting
equipment.’’ The SBA has developed a
small business size standard for Radio
and Television Broadcasting and
Wireless Communications Equipment
Manufacturing, which is: all such firms
having 750 or fewer employees.15
According to Census Bureau data for
2002, there were a total of 1,041
establishments in this category that
operated for the entire year. Of this
total, 1,010 had employment of under
500, and an additional 13 had
employment of 500 to 999. Thus, under
this size standard, the majority of firms
can be considered small.16
47. Wireless Service Providers. The
SBA has developed a small business
size standard for wireless firms within
the two broad economic census
categories of ‘‘Paging’’ 17 and ‘‘Cellular
and Other Wireless
Telecommunications.’’ 18 Under both
categories, the SBA deems a wireless
15 NAICS
code 334220.
code 11210.
17 13 CFR 121.201, NAICS code 517211.
18 13 CFR 121.201, NAICS code 517212.
16 NAICS
VerDate Nov<24>2008
18:53 May 13, 2009
Jkt 217001
business to be small if it has 1,500 or
fewer employees. For the census
category of Paging, Census Bureau data
for 2002 show that there were 807 firms
in this category that operated for the
entire year. 19 Of this total, 804 firms
had employment of 999 or fewer
employees, and three firms had
employment of 1,000 employees or
more.20 Thus, under this category and
associated small business size standard,
the majority of firms can be considered
small. For the census category of
Cellular and Other Wireless
Telecommunications, Census Bureau
data for 2002 show that there were 1,397
firms in this category that operated for
the entire year.21 Of this total, 1,378
firms had employment of 999 or fewer
employees, and 19 firms had
employment of 1,000 employees or
more.22 Thus, under this second
category and size standard, the majority
of firms can, again, be considered small.
48. Public Safety Radio Services.
Public Safety radio services include
police, fire, local government, forestry
conservation, highway maintenance,
and emergency medical services.23 For
19 U.S. Census Bureau, 2002 Economic Census,
Subject Series: ‘‘Information,’’ Table 5, Employment
Size of Firms for the United States: 2002, NAICS
code 517211 (issued Nov. 2005).
20 Id. The census data do not provide a more
precise estimate of the number of firms that have
employment of 1,500 or fewer employees; the
largest category provided is for firms with ‘‘1000
employees or more.’’
21 U.S. Census Bureau, 2002 Economic Census,
Subject Series: ‘‘Information,’’ Table 5, Employment
Size of Firms for the United States: 2002, NAICS
code 517212 (issued Nov. 2005).
22 Id. The census data do not provide a more
precise estimate of the number of firms that have
employment of 1,500 or fewer employees; the
largest category provided is for firms with ‘‘1000
employees or more.’’
23 With the exception of the special emergency
service, these services are governed by Subpart B
of part 90 of the Commission’s Rules, 47 CFR
90.15–90.27. The police service includes
approximately 27,000 licensees that serve state,
county, and municipal enforcement through
telephony (voice), telegraphy (code) and teletype
and facsimile (printed material). The fire radio
service includes approximately 23,000 licensees
comprised of private volunteer or professional fire
companies as well as units under governmental
control. The local government service that is
presently comprised of approximately 41,000
licensees that are state, county, or municipal
entities that use the radio for official purposes not
covered by other public safety services. There are
approximately 7,000 licensees within the forestry
service which is comprised of licensees from state
departments of conservation and private forest
organizations who set up communications networks
among fire lookout towers and ground crews. The
approximately 9,000 state and local governments
are licensed to highway maintenance service
provide emergency and routine communications to
aid other public safety services to keep main roads
safe for vehicular traffic. The approximately 1,000
licensees in the Emergency Medical Radio Service
(EMRS) use the 39 channels allocated to this service
for emergency medical service communications
related to the delivery of emergency medical
PO 00000
Frm 00064
Fmt 4700
Sfmt 4700
small businesses in this category, the
above small business size standard
applies to 1500 or fewer employees.
There are a total of approximately
127,540 licensees in these services.
Governmental entities 24 as well as
private businesses comprise the
licensees for these services. All
governmental entities with populations
of less than 50,000 fall within the
definition of a small entity.25
D. Description of Projected Reporting,
Recordkeeping, and Other Compliance
Requirements for Small Entities
49. The Commission is using the
licensing approach for the entire 401–
406 MHz MedRadio band that is
identical to that used for the existing
MICS band at 402–405 MHz. Thus,
rather than require individual
transmitter licensing, the Commission
authorizes operation by rule within the
Citizens Band (CB) Radio Service under
part 95 of our Rules and pursuant to
Section 307(e) of the Communications
Act.26 Licensing will be accomplished
through adherence to applicable
technical standards and other operating
rules (unlicensed operations). The
Commission concludes that this
approach is beneficial because it would
minimize the administrative burden on
prospective licensees as compared with
an individual licensing scheme.
E. Steps Taken To Minimize the
Significant Economic Impact on Small
Entities, and Significant Alternatives
Considered
50. The RFA requires an agency to
describe any significant alternatives that
it has considered in reaching its
proposed approach, which may include
the following four alternatives (among
others): (1) The establishment of
differing compliance or reporting
requirements or timetables that take into
account the resources available to small
entities; (2) the clarification,
consolidation, or simplification of
treatment. 47 CFR 90.15–90.27. The approximately
20,000 licensees in the special emergency service
include medical services, rescue organizations,
veterinarians, handicapped persons, disaster relief
organizations, school buses, beach patrols,
establishments in isolated areas, communications
standby facilities, and emergency repair of public
communications facilities. 47 CFR 90.33–90.55.
24 47 CFR 1.1162.
25 5 U.S.C. 601(5).
26 See Medtronic Petition at i, 16, and Appendix
A, at proposed § 95.1601. We note that 47 U.S.C.
307(e)(3) provides that the term ‘‘citizens band
radio service’’ shall have the meaning given it by
the Commission by rule. 47 U.S.C. 307(e)(1)
provides that upon determination by the
Commission that an authorization serves the public
interest, convenience, and necessity, the
Commission may by rule authorize the operation of
radio stations without individual licenses in the
citizens band radio service.
E:\FR\FM\14MYR1.SGM
14MYR1
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
compliance or reporting requirements
under the rule for small entities; (3) the
use of performance, rather than design,
standards; and (4) an exemption from
coverage of the rule, or any part thereof,
for small entities.27
51. In the Report and Order the
Commission established a new Medical
Device Radiocommunication Service
(MedRadio Service) under part 95,
which will encompass all medical
devices permitted to operate in the 401–
406 MHz band. It sought comment on
the options concerning whether and
how the five megahertz of spectrum that
would comprise this MedRadio band
could be divided among the evolving
varieties of both implanted and bodyworn medical transmitters, including
low-power, low-duty-cycle (LPLDC)
devices that do not employ ‘‘listenbefore-talk’’ (LBT) frequency monitoring
spectrum access techniques.
52. Report to Congress: The
Commission will send a copy of the
Report and Order, including this FRFA,
in a report to be sent to Congress
pursuant to the Congressional Review
Act.28 In addition, the Commission will
send a copy of the Report and Order,
including this FRFA, to the Chief
Counsel for Advocacy of the SBA.
Ordering Clauses
53. Pursuant to the authority
contained in Sections 4(i), 301, 302,
303(e), 303(f) and 303(r) of the
Communications Act of 1934, as
amended, 47 USC Sections 154(i), 301,
302, 303(e), 303(f) and 303(r), this
Report and Order is adopted and parts
1, 2 and 95 of the Commission’s Rules
are amended as set forth in Final Rules
27 See
jlentini on PROD1PC65 with RULES
28 See
18:53 May 13, 2009
List of Subjects
47 CFR Part 1
Administrative practice and
procedure.
47 CFR Parts 2 and 95
Communications equipment, Radio,
Reporting and recordkeeping
requirements.
Federal Communications Commission.
Marlene H. Dortch,
Secretary.
Final Rules
For the reasons discussed in the
preamble, the Federal Communications
Commission amends 47 CFR parts 1, 2,
and 95 to read as follows:
■
PART 1—PRACTICE AND
PROCEDURE
1. The authority citation for part 1
continues to read as follows:
■
Authority: 15 U.S.C. 79 et seq.; 47 U.S.C.
151, 154(i), 154(j), 155, 157, 225, 303(r), and
309.
5 U.S.C. 603(c).
5 U.S.C. 801(a)(1)(A).
VerDate Nov<24>2008
effective 90 days after publication in the
Federal Register.
54. The Commission grants in part,
consistent with the terms of this order,
DexCom, Inc.’s request for extension of
waiver, and otherwise deny the request
in all other respects.
55. ET Docket No. 03–92 is
terminated.
56. The Commission’s Consumer and
Governmental Affairs Bureau, Reference
Information Center, shall send a copy of
this Report and Order, including the
Final Regulatory Flexibility Analysis in
Appendix C, to the Chief Counsel for
Advocacy of the Small Business
Administration.
Jkt 217001
PO 00000
Frm 00065
Fmt 4700
Sfmt 4700
22703
2. Section 1.1307 is amended by
revising the fourth sentence in
paragraph (b)(2) to read as follows:
■
§ 1.1307 Actions that may have a
significant environmental effect, for which
Environmental Assessments (EAs) must be
prepared.
*
*
*
*
*
(b) * * *
(2) * * * Equipment authorized for
use in the Medical Device
Radiocommunication Service
(MedRadio) as a medical implant or
body-worn transmitter (as defined in
Appendix 1 to Subpart E of part 95 of
this chapter) is subject to routine
environmental evaluation for RF
exposure prior to equipment
authorization, as specified in § 2.1093 of
this chapter by finite difference time
domain computational modeling or
laboratory measurement techniques.
* * *
*
*
*
*
*
PART 2—FREQUENCY ALLOCATIONS
AND RADIO TREATY MATTERS;
GENERAL RULES AND REGULATIONS
3. The authority citation for part 2
continues to read as follows:
■
Authority: 47 U.S.C. 154, 302a, 303, and
336, unless otherwise noted.
4. Section 2.106, the Table of
Frequency Allocations, is amended as
follows:
■ a. Revise page 24.
■ b. In the list of United States (US)
footnotes, revise footnote US345.
The revisions read as follows:
■
§ 2.106
*
*
Table of Frequency Allocations.
*
*
BILLING CODE 6712–01–P
E:\FR\FM\14MYR1.SGM
14MYR1
*
22704
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
*
*
*
*
*
United States (US) Footnotes
*
*
*
*
*
US345 In the band 401–406 MHz, the
mobile, except aeronautical mobile,
service is allocated on a secondary basis
and is limited to, with the exception of
military tactical mobile stations,
Medical Device Radiocommunication
Service (MedRadio) operations.
MedRadio stations are authorized by
rule on the condition that harmful
interference is not caused to stations in
the meteorological aids, meteorologicalsatellite, and Earth exploration-satellite
services, and that MedRadio stations
accept interference from stations in the
meteorological aids, meteorologicalsatellite, and Earth exploration-satellite
services.
*
*
*
*
*
5. Section 2.1093 is amended by
revising paragraph (c) to read as follows:
jlentini on PROD1PC65 with RULES
■
§ 2.1093 Radiofrequency radiation
exposure evaluation: portable devices.
*
*
*
VerDate Nov<24>2008
*
*
18:53 May 13, 2009
Jkt 217001
(c) Portable devices that operate in the
Cellular Radiotelephone Service, the
Personal Communications Service
(PCS), the Satellite Communications
Services, the General Wireless
Communications Service, the Wireless
Communications Service, the Maritime
Services, the Specialized Mobile Radio
Service, the 4.9 GHz Band Service, the
Wireless Medical Telemetry Service
(WMTS) and the Medical Device
Radiocommunication Service
(MedRadio), authorized under subpart H
of part 22 of this chapter, parts 24, 25,
26, 27, 80 and 90 of this chapter,
subparts H and I of part 95 of this
chapter, and unlicensed personal
communication service, unlicensed NII
devices and millimeter wave devices
authorized under subparts D and E,
15.253, 15.255 and 15.257 of this
chapter are subject to routine
environmental evaluation for RF
exposure prior to equipment
authorization or use. All other portable
transmitting devices are categorically
excluded from routine environmental
evaluation for RF exposure prior to
equipment authorization or use, except
as specified in 1.1307(c) and 1.1307(d)
PO 00000
Frm 00066
Fmt 4700
Sfmt 4700
of this chapter. Applications for
equipment authorization of portable
transmitting devices subject to routine
environmental evaluation must contain
a statement confirming compliance with
the limits specified in paragraph (d) of
this section as part of their application.
Technical information showing the
basis for this statement must be
submitted to the Commission upon
request.
*
*
*
*
*
■ 6. Section 2.1204 is amended by
revising paragraph (a)(9) to read as
follows:
§ 2.1204
Import conditions.
(a) * * *
*
*
*
*
*
(9) The radio frequency device is a
medical implant transmitter inserted in
a person or a medical body-worn
transmitter as defined in part 95,
granted entry into the United States or
is a control transmitter associated with
such an implanted or body-worn
transmitter, provided, however that the
transmitters covered by this provision
otherwise comply with the technical
requirements applicable to transmitters
E:\FR\FM\14MYR1.SGM
14MYR1
ER14MY09.000
BILLING CODE 6712–01–C
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
authorized to operate in the Medical
Device Radiocommunication Service
(MedRadio) under part 95 of this
chapter. Such transmitters are permitted
to be imported without the issuance of
a grant of equipment authorization only
for the personal use of the person in
whom the medical implant transmitter
has been inserted or on whom the
medical body-worn transmitter is
applied.
*
*
*
*
*
in the MedRadio service) must be
certificated except for such transmitters
that are not marketed for use in the
United States, but which otherwise
comply with the MedRadio Service
technical requirements and are operated
in the United States by individuals who
have traveled to the United States from
abroad.
*
*
*
*
*
■ 11. Section 95.605 is revised to read
as follows:
PART 95—PERSONAL RADIO
SERVICES
§ 95.605
7. The authority citation for part 95
continues to read as follows:
■
Authority: Sections 4, 303, 48 Stat. 1066,
1082, as amended; 47 U.S.C. 154, 303.
8. Section 95.401 is amended by
revising paragraph (d) to read as
follows:
■
§ 95.401 (CB Rule 1) What are the Citizens
Band Radio Services?
*
*
*
*
*
(d) The Medical Device
Radiocommunication Service
(MedRadio)—an ultra-low power radio
service, for the transmission of nonvoice data for the purpose of facilitating
diagnostic and/or therapeutic functions
involving implanted and body-worn
medical devices. The rules for this
service are contained in subpart I of this
part.
*
*
*
*
*
■ 9. Section 95.601 is amended by
revising the last sentence to read as
follows:
§ 95.601
Basis and purpose.
* * * The Personal Radio Services
are the GMRS (General Mobile Radio
Service)—subpart A, the Family Radio
Service (FRS)—subpart B, the R/C
(Radio Control Radio Service)—subpart
C, the CB (Citizens Band Radio
Service)—subpart D, the Low Power
Radio Service (LPRS)—subpart G, the
Wireless Medical Telemetry Service
(WMTS)—subpart H, the Medical
Device Radiocommunication Service
(MedRadio)—subpart I, the Multi-Use
Radio Service (MURS)—subpart J, and
Dedicated Short-Range Communications
Service On-Board Units (DSRCS–
OBUs)—subpart L.
■ 10. Section 95.603 is amended by
revising paragraph (f) to read as follows:
jlentini on PROD1PC65 with RULES
§ 95.603
Certification required.
*
*
*
*
*
(f) Each Medical Device
Radiocommunication Service
(MedRadio) transmitter (a transmitter
that operates or is intended to operate
VerDate Nov<24>2008
18:53 May 13, 2009
Jkt 217001
Certification procedures.
Any entity may request certification
for its transmitter when the transmitter
is used in the GMRS, FRS, R/C, CB,
218–219 MHz Service, LPRS, MURS, or
MedRadio Service following the
procedures in part 2 of this chapter.
Dedicated Short-Range Communications
Service On-Board Units (DSRCS–OBUs)
must be certified in accordance with
subpart L of this part and subpart J of
part 2 of this chapter.
■ 12. Section 95.628 is revised to read
as follows:
§ 95.628
MedRadio transmitters.
(a) Frequency monitoring. Except as
provided in (b) of this section, all
MedRadio programmer/control
transmitters operating in the 401–406
MHz band must operate under the
control of a monitoring system that
incorporates a mechanism for
monitoring the channel or channels that
the MedRadio system devices intend to
occupy. The monitoring system antenna
shall be the antenna normally used by
the programmer/control transmitter for a
communications session. Before the
monitoring system of a MedRadio
programmer/control transmitter initiates
a MedRadio communications session,
the following access criteria must be
met:
(1) The monitoring system bandwidth
measured at its 20 dB down points must
be equal to or greater than the emission
bandwidth of the intended
transmission.
(2) Within 5 seconds prior to
initiating a communications session,
circuitry associated with a MedRadio
programmer/control transmitter must
monitor the channel or channels the
system devices intend to occupy for a
minimum of 10 milliseconds per
channel.
(3) Based on use of an isotropic
monitoring system antenna, the
monitoring threshold power level must
not be more than 10logB(Hz) ¥150
(dBm/Hz) + G(dBi), where B is the
emission bandwidth of the MedRadio
communications session transmitter
having the widest emission and G is the
PO 00000
Frm 00067
Fmt 4700
Sfmt 4700
22705
MedRadio programmer/control
transmitter monitoring system antenna
gain relative to an isotropic antenna. For
purposes of showing compliance with
the above provision, the above
calculated threshold power level must
be increased or decreased by an amount
equal to the monitoring system antenna
gain above or below the gain of an
isotropic antenna, respectively.
(4) If no signal in a MedRadio channel
above the monitoring threshold power
level is detected, the MedRadio
programmer/control transmitter may
initiate a MedRadio communications
session involving transmissions to and
from a medical implant or medical
body-worn device on that channel. The
MedRadio communications session may
continue as long as any silent period
between consecutive data transmission
bursts does not exceed 5 seconds. If a
channel meeting the criteria in
paragraph (a)(3) of this section is
unavailable, the channel with the lowest
ambient power level may be accessed.
(5) When a channel is selected prior
to a MedRadio communications session,
it is permissible to select an alternate
channel for use if communications are
interrupted, provided that the alternate
channel selected is the next best choice
using the above criteria. The alternate
channel may be accessed in the event a
communications session is interrupted
by interference. The following criteria
must be met:
(i) Before transmitting on the alternate
channel, the channel must be monitored
for a period of at least 10 milliseconds.
(ii) The detected power level during
this 10 millisecond or greater
monitoring period must be no higher
than 6dB above the power level detected
when the channel was chosen as the
alternate channel.
(iii) In the event that this alternate
channel provision is not used by the
MedRadio system or if the criteria in
paragraphs (a)(5)(i) and (ii) are not met,
a channel must be selected using the
access criteria specified in paragraphs
(a)(1) through (a)(4) of this section.
(6) As used in this section, the
following definitions apply:
(i) Emission bandwidth— Measured
as the width of the signal between the
points on either side of carrier center
frequency that are 20 dB down relative
to the maximum level of the modulated
carrier. Compliance will be determined
using instrumentation employing a peak
detector function and a resolution
bandwidth approximately equal to 1%
of the emission bandwidth of the device
under test.
(ii) MedRadio channel—Any
continuous segment of spectrum in the
MedRadio band that is equal to the
E:\FR\FM\14MYR1.SGM
14MYR1
jlentini on PROD1PC65 with RULES
22706
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
emission bandwidth of the device with
the largest bandwidth that is to
participate in a MedRadio
communications session.
Note to paragraph (a)(6)(ii): The rules
do not specify a channeling scheme for
use by MedRadio systems.
(iii) MedRadio communications
session—A collection of transmissions,
that may or may not be continuous,
between MedRadio system devices.
(b) Exceptions to frequency
monitoring criteria. MedRadio devices
or communications sessions that meet
any one of the following criteria are not
required to use the access criteria set
forth in paragraph (a) of this section:
(1) MedRadio communications
sessions initiated by a medical implant
event.
(2) MedRadio devices operating in
either the 401–401.85 MHz or 405–406
MHz bands, provided that the transmit
power is not greater than 250 nanowatts
EIRP and the duty cycle for such
transmissions does not exceed 0.1%,
based on the total transmission time
during a one-hour interval.
(3) MedRadio devices operating in the
401.85–402 MHz band, provided that
the transmit power is not greater than 25
microwatts EIRP and the duty cycle for
such transmissions does not exceed
0.1%, based on the total transmission
time during a one-hour interval.
(4) MedRadio devices operating with
a total emission bandwidth not
exceeding 300 kHz centered at 403.65
MHz, provided that the transmit power
is not greater than 100 nanowatts EIRP
and the duty cycle for such
transmissions does not exceed 0.01%,
based on the total transmission time
during a one-hour interval.
(c) Operating frequency. MedRadio
stations authorized under this part may
operate on frequencies in the 401–406
MHz band as follows provided that the
out-of-band emissions are attenuated in
accordance with § 95.635:
(1) MedRadio stations associated with
medical implant devices, which
incorporate a frequency monitoring
system as set forth in paragraph (a) of
this section, may operate on any of the
frequencies in the 401–406 MHz band.
(2) MedRadio stations associated with
medical implant devices, which do not
incorporate a frequency monitoring
system as set forth in paragraph (a) of
this section, may operate on any
frequency in 401–402 MHz or 405–406
MHz bands, or at 403.65 MHz in the
402–405 MHz band.
(3) MedRadio stations associated with
medical body-worn devices, regardless
of whether a frequency monitoring
system as set forth in paragraph (a) of
this section is employed, may operate
VerDate Nov<24>2008
18:53 May 13, 2009
Jkt 217001
on any of the frequencies in the 401–402
MHz or 405–406 MHz bands.
(4) MedRadio stations that are used
externally to evaluate the efficacy of a
more permanent medical implant
device, regardless of whether a
frequency monitoring system as set forth
in paragraph (a) of this section is
employed, may operate on any of the
frequencies in the 402–405 MHz band,
provided that:
(i) Such external body-worn operation
is limited solely to evaluating with a
patient the efficacy of a fully implanted
permanent medical device that is
intended to replace the temporary bodyworn device;
(ii) RF transmissions from the external
device must cease following the patient
evaluation period, which may not
exceed 30 days, except where a health
care practitioner determines that
additional time is necessary due to
unforeseen circumstances;
(iii) The maximum output power of
the temporary body-worn device shall
not exceed 200 nW EIRP; and
(iv) The temporary body-worn device
must comply fully with all other
MedRadio rules applicable to medical
implant device operation in the 402–405
MHz band.
(d) Authorized bandwidth. The
authorized bandwidth of the emission
from a MedRadio station operating
between 402–405 MHz shall not exceed
300 kHz, and no communications
session involving MedRadio stations
shall use more than a total of 300 kHz
of bandwidth during such a session. The
authorized bandwidth of the emission
from a MedRadio station operating
between 401–401.85 MHz or 405–406
MHz shall not exceed 100 kHz, and no
communications session involving
MedRadio stations shall use more than
a total of 100 kHz of bandwidth during
such a session. The authorized
bandwidth of the emission from a
MedRadio station operating between
401.85–402 MHz shall not exceed 150
kHz, and no communications session
involving MedRadio stations shall use
more than a total of 150 kHz of
bandwidth during such a session.
Note to paragraph (d): This provision
does not preclude full duplex or half
duplex communications provided that
the total amount of bandwidth utilized
by all of the MedRadio channels
employed in such a MedRadio
communications session does not
exceed 300 kHz in the 402–405 MHz
band, or 100 kHz in the 401–402 MHz
and 405–406 MHz bands.
(e) Frequency stability. Each
transmitter in the MedRadio service
must maintain a frequency stability of
PO 00000
Frm 00068
Fmt 4700
Sfmt 4700
±100 ppm of the operating frequency
over the range:
(1) 25° C to 45° C in the case of
medical implant transmitters; and
(2) 0° C to 55° C in the case of
MedRadio programmer/control
transmitters and MedRadio body-worn
transmitters.
(f) Shared access. The provisions of
this section shall not be used to extend
the range of spectrum occupied over
space or time for the purpose of denying
fair access to spectrum for other
MedRadio systems.
(g) Measurement procedures. (1)
MedRadio transmitters shall be tested
for frequency stability, radiated
emissions and EIRP limit compliance in
accordance with paragraphs (g)(2) and
(g)(3) of this section.
(2) Frequency stability testing shall be
performed over the temperature range
set forth in (e) of this section.
(3) Radiated emissions and EIRP limit
measurements limit may be determined
by measuring the radiated field from the
equipment under test at 3 meters and
calculating the EIRP. The equivalent
radiated field strength at 3 meters for 25
microwatts, 250 nanowatts, and 100
nanowatts EIRP is 18.2, 1.8, or 1.2 mV/
meter, respectively, when measured on
an open area test site; or 9.1, 0.9, or 0.6
mV/meter, respectively, when measured
on a test site equivalent to free space
such as a fully anechoic test chamber.
Power measurements for transmissions
by stations authorized under this
section may be made either in
accordance with a Commissionapproved peak power technique, or the
following. Peak transmit power must be
measured over any interval of
continuous transmission using
instrumentation calibrated in terms of
an rms-equivalent voltage. The
measurement results shall be properly
adjusted for any instrument limitations,
such as detector response times, limited
resolution bandwidth capability when
compared to the emission bandwidth,
sensitivity, etc., so as to obtain a true
peak measurement for the emission in
question over the full bandwidth of the
channel.
(i) For a transmitter intended to be
implanted in a human body, radiated
emissions and EIRP measurements for
transmissions by stations authorized
under this section may be made in
accordance with a Commissionapproved human body simulator and
test technique. A formula for a suitable
tissue substitute material is defined in
OET Bulletin 65 Supplement C (01–01).
■ 13. Section 95.631 is amended by
revising paragraph (h) to read as
follows:
E:\FR\FM\14MYR1.SGM
14MYR1
22707
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
§ 95.631
Emission types.
*
*
*
*
*
(h) A MedRadio station may transmit
any emission type appropriate for
communications in this service. Voice
communications, however, are
prohibited.
*
*
*
*
*
■ 14. Section 95.633 is amended by
revising paragraph (e) to read as follows:
§ 95.633
Emission bandwidth.
*
*
*
*
*
(e) For transmitters in the MedRadio
Service:
(1) For stations operating in 402–405
MHz, the maximum authorized
emission bandwidth is 300 kHz. For
stations operating in 401–401.85 MHz or
405–406 MHz, the maximum authorized
emission bandwidth is 100 kHz, and
stations operating in 401.85–402 MHz,
the maximum authorized emission
bandwidth is 150 kHz.
(2) Lesser emission bandwidths may
be employed, provided that the
unwanted emissions are attenuated as
provided in § 95.635. See §§ 95.628(g)
and 95.639(f) regarding maximum
transmitter power and measurement
procedures.
(3) Emission bandwidth will be
determined by measuring the width of
the signal between points, one below
the carrier center frequency and one
above the carrier center frequency, that
are 20 dB down relative to the
maximum level of the modulated
carrier. Compliance with the emission
bandwidth limit is based on the use of
measurement instrumentation
employing a peak detector function with
an instrument resolution bandwidth
approximately equal to 1.0 percent of
the emission bandwidth of the device
under measurement.
*
*
*
*
*
15. Section 95.635 is amended by
revising the table to paragraph (b), and
by revising paragraph (d) to read as
follows:
■
§ 95.635
*
Unwanted radiation.
*
*
(b) * * *
*
*
Transmitter
Emission type
GMRS ..............................................
A1D, A3E, F1D, G1D, F3E, G3E with filtering ......................................
A1D, A3E, F1D, G1D, F3E, G3E without filtering .................................
H1D, J1D, R1D, H3E, J3E, R3E ...........................................................
F3E with filtering ....................................................................................
(1),
(5),
(2),
(1),
(3),
(6),
(4),
(3),
(7).
(7).
(7).
(7).
As specified in § 95.631(b) ....................................................................
As specified in § 95.631(b) ....................................................................
A1D, A3E ...............................................................................................
H1D, J1D, R1D, H3E, J3E, R3E ...........................................................
A1D, A3E type accepted before September 10, 1976 ..........................
H1D, J1D, R1D, H3E, J3E, R3E type accepted before September 10,
1986.
As specified in paragraph (c).
As specified in paragraph (d).
As specified in paragraph (f) of this section.
(1),
(1),
(1),
(2),
(1),
(2),
(3),
(3),
(3),
(4),
(3),
(4),
(7).
(7), (10), (11), (12).
(8), (9).
(8), (9).
(7).
(7).
FRS .................................................
R/C:
27 MHz .....................................
72–76 MHz ...............................
CB ...................................................
LPRS ...............................................
MedRadio ........................................
DSRCS–OBU ..................................
*
*
*
*
*
(d) For transmitters designed to
operate in the MedRadio service,
emissions shall be attenuated in
accordance with the following:
(paragraphs (d)(1) through (d)(5) pertain
Applicable paragraphs (b)
to MedRadio transmitters operating in
the 402–405 MHz band; paragraphs
(d)(6) through (d)(10) pertain to
MedRadio transmitters operating in the
401–402 MHz or 405–406 MHz bands).
(1) Emissions from a MedRadio
transmitter more than 250 kHz outside
of the 402–405 MHz band shall be
attenuated to a level no greater than the
following field strength limits:
Frequency
(MHz)
Field strength
(μV/m)
30–88 ...........................................................................................................................................................
88–216 .........................................................................................................................................................
216–960 .......................................................................................................................................................
960 and above .............................................................................................................................................
Measurement
distance
(m)
100
150
200
500
jlentini on PROD1PC65 with RULES
Note—At band edges, the tighter limit applies.
(2) The emission limits shown in the
table of paragraph (d)(1) are based on
measurements employing a CISPR
quasi-peak detector except that above 1
GHz, the limit is based on
measurements employing an average
detector. Measurements above 1 GHz
shall be performed using a minimum
resolution bandwidth of 1 MHz. See
also § 95.605.
(3) The emissions from a MedRadio
transmitter must be measured to at least
VerDate Nov<24>2008
18:53 May 13, 2009
Jkt 217001
the tenth harmonic of the highest
fundamental frequency designed to be
emitted by the transmitter.
(4) Emissions within the 402–405
MHz band more than 150 kHz away
from the center frequency of the
spectrum the transmission is intended
to occupy will be attenuated below the
transmitter output power by at least 20
dB. Compliance with this limit is based
on the use of measurement
instrumentation employing a peak
PO 00000
Frm 00069
Fmt 4700
Sfmt 4700
detector function with an instrument
resolution bandwidth approximately
equal to 1.0 percent of the emission
bandwidth of the device under
measurement.
(5) Emissions 250 kHz or less that are
above or below the 402–405 MHz band
will be attenuated below the maximum
permitted output power by at least 20
dB. Compliance with this limit is based
on the use of measurement
instrumentation employing a peak
E:\FR\FM\14MYR1.SGM
14MYR1
3
3
3
3
22708
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
detector function with an instrument
resolution bandwidth approximately
equal to 1.0 percent of the emission
bandwidth of the device under
measurement.
(6) Emissions from a MedRadio
transmitter operating in the 401–402
MHz or 405–406 MHz bands that are
more than 100 kHz outside of either the
401–402 MHz or 405–406 MHz bands,
and all emissions from such transmitter
in the band 406.000–406.100 MHz shall
be attenuated to a level no greater than
the following field strength limits:
Field strength
(μV/m)
Frequency (MHz)
30–88 ...........................................................................................................................................................
88–216 .........................................................................................................................................................
216–960 .......................................................................................................................................................
960 and above .............................................................................................................................................
Measurement
distance (m)
100
150
200
500
3
3
3
3
jlentini on PROD1PC65 with RULES
Note—At band edges, the tighter limit applies.
(7) The emission limits shown in
paragraph (d)(6) are based on
measurements employing a CISPR
quasi-peak detector except that above 1
GHz, the limit is based on
measurements employing an average
detector. Measurements above 1 GHz
shall be performed using a minimum
resolution bandwidth of 1 MHz. See
also § 95.605.
(8) The emissions from a MedRadio
transmitter operating in the MedRadio
bands (between 401–402 MHz or 405–
406 MHz) must be measured to at least
the tenth harmonic of the highest
fundamental frequency designed to be
emitted by the transmitter.
(9) Emissions between 401–401.85
MHz or 405–406 MHz within the
MedRadio bands that are more than 50
kHz away from the center frequency of
the spectrum the transmission is
intended to occupy (or more than 75
kHz away from the center frequency of
MedRadio transmitters operating
between 401.85–402 MHz) shall be
attenuated below the transmitter output
power by at least 20 dB. Compliance
with this limit is based on the use of
measurement instrumentation
employing a peak detector function with
an instrument resolution bandwidth
approximately equal to 1.0 percent of
the emission bandwidth of the device
under measurement.
(10) Emissions 100 kHz or less below
401 MHz or above 406 MHz shall be
attenuated below the maximum
permitted output power by at least 20
dB. Compliance with this limit is based
on the use of measurement
instrumentation employing a peak
detector function with an instrument
resolution bandwidth approximately
equal to 1.0 percent of the emission
bandwidth of the device under
measurement.
*
*
*
*
*
■ 16. Section 95.639 is amended by
revising paragraph (f) to read as follows:
§ 95.639
*
*
Maximum transmitter power.
*
VerDate Nov<24>2008
*
*
18:53 May 13, 2009
Jkt 217001
(f) In the MedRadio Service for
transmitters that are not excepted under
§ 95.628(b) from the frequency
monitoring requirements of § 95.628(a),
the maximum radiated power in any
300 kHz bandwidth by MedRadio
transmitters operating at 402–405 MHz,
or in any 100 kHz bandwidth by
MedRadio transmitters operating at
401–402 MHz or 405–406 MHz shall not
exceed 25 microwatts EIRP. For
transmitters that are excepted under
§ 95.628(b) from the frequency
monitoring requirements of § 95.628(a),
the power radiated by any station
operating in 402–405 MHz shall not
exceed 100 nanowatts EIRP confined to
a maximum total emission bandwidth of
300 kHz centered at 403.65 MHz. For
transmitters that are excepted under
§ 95.628(b) from the frequency
monitoring requirements of § 95.628(a),
the power radiated by any station
operating in 401–401.85 MHz or 405–
406 MHz shall not exceed 250
nanowatts EIRP in any 100 kHz
bandwidth and in 401.85–402 MHz
shall not exceed 25 microwatts in the
150 kHz bandwidth. See §§ 95.633(e).
The antenna associated with any
MedRadio transmitter must be supplied
with the transmitter and shall be
considered part of the transmitter
subject to equipment authorization.
Compliance with these EIRP limits may
be determined as set forth in § 95.628(g).
*
*
*
*
*
■ 17. Section 95.649 is revised to read
as follows:
§ 95.649
Power capability.
No CB, R/C, LPRS, FRS, MedRadio,
MURS, or WMTS unit shall incorporate
provisions for increasing its transmitter
power to any level in excess of the
limits specified in § 95.639.
■ 18. Section 95.651 is revised to read
as follows:
§ 95.651
Crystal control required.
All transmitters used in the Personal
Radio Services must be crystal
controlled, except an R/C station that
PO 00000
Frm 00070
Fmt 4700
Sfmt 4700
transmits in the 26–27 MHz frequency
band, a FRS unit, a LPRS unit, a MURS
unit, a MedRadio transmitter, or a
WMTS unit.
■ 19. Appendix 1 to Subpart E of Part
95—Glossary of Terms is amended by
removing the definition of ‘‘Medical
Implant Communications Service
(MICS) transmitter’’, ‘‘MICS
programmer/control transmitter’’ and
‘‘MICS’’; and by revising the definitions
of ‘‘EIRP’’, ‘‘Medical implant
transmitter’’; and by adding the
definitions of ‘‘Medical body-worn
device’’, ‘‘Medical body-worn
transmitter’’, ‘‘MedRadio programmer/
control transmitter’’, ‘‘MedRadio
Service’’ and ‘‘MedRadio transmitter’’ in
alphabetical order to read as follows:
APPENDIX 1 TO SUBPART E OF PART
95—GLOSSARY OF TERMS
*
*
*
*
*
EIRP. Effective Isotropic Radiated Power.
Antenna input power times gain for freespace or in-tissue measurement
configurations required by MedRadio,
expressed in watts, where the gain is
referenced to an isotropic radiator.
*
*
*
*
*
Medical body-worn device. Apparatus that
is placed on or in close proximity to the
human body (e.g., within a few centimeters)
for the purpose of performing diagnostic or
therapeutic functions.
Medical body-worn transmitter. A
MedRadio transmitter intended to be placed
on or in close proximity to the human body
(e.g., within a few centimeters) used to
facilitate communications with other medical
communications devices for purposes of
delivering medical therapy to a patient or
collecting medical diagnostic information
from a patient.
*
*
*
*
*
Medical implant transmitter. A MedRadio
transmitter in which both the antenna and
transmitter device are designed to operate
within a human body for the purpose of
facilitating communications from a medical
implant device.
MedRadio programmer/control transmitter.
A MedRadio transmitter that operates or is
designed to operate outside of a human body
for the purpose of communicating with a
receiver, or for triggering a transmitter,
E:\FR\FM\14MYR1.SGM
14MYR1
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
connected to a medical implant device or to
a medical body-worn device used in the
MedRadio Service; and which also typically
includes a frequency monitoring system that
initiates a MedRadio communications
session.
MedRadio Service. Medical Device
Radiocommunication Service.
MedRadio transmitter. A transmitter
authorized to operate in the MedRadio
service.
*
■
*
*
*
*
20. Revise Subpart I to read as follows:
Subpart I—Medical Device
Radiocommunication Service (MedRadio)
Sec.
95.1201
95.1203
95.1205
95.1207
95.1209
95.1211
95.1213
95.1215
95.1217
95.1219
95.1221
Eligibility.
Authorized locations.
Station identification.
Station inspection.
Permissible communications.
Channel use policy.
Antennas.
Disclosure policies.
Labeling requirements.
Marketing limitations.
RF exposure.
jlentini on PROD1PC65 with RULES
Eligibility.
Operation in the MedRadio service is
permitted by rule and without an
individual license issued by the FCC.
Duly authorized health care
professionals are permitted to operate
MedRadio transmitters. Persons may
also operate MedRadio transmitters to
the extent the transmitters are
incorporated into implanted or bodyworn medical devices that are used by
the person at the direction of a duly
authorized health care professional; this
includes medical devices that have been
implanted in that person or placed on
the body of that person by or under the
direction of a duly authorized health
care professional. Manufacturers of
medical devices that include MedRadio
transmitters, and their representatives,
are authorized to operate transmitters in
this service for the purpose of
demonstrating such equipment to duly
authorized health care professionals. No
entity that is a foreign government or
which is acting in its capacity as a
representative of a foreign government
is eligible to operate a MedRadio
transmitter. The term ‘‘duly authorized
health care professional’’ means a
physician or other individual
authorized under state or federal law to
provide health care services. Operations
that comply with the requirements of
this part may be conducted under
manual or automatic control.
VerDate Nov<24>2008
18:53 May 13, 2009
Jkt 217001
Authorized locations.
MedRadio operation is authorized
anywhere CB station operation is
authorized under § 95.405.
§ 95.1205
Station identification.
A station is not required to transmit
a station identification announcement.
§ 95.1207
Station inspection.
Any non-implanted MedRadio
transmitter must be made available for
inspection upon request by an
authorized FCC representative. Persons
operating implanted or body-worn
MedRadio transmitters shall cooperate
reasonably with duly authorized FCC
representatives in the resolution of
interference.
§ 95.1209
Subpart I—Medical Device
Radiocommunication Service
(MedRadio)
§ 95.1201
§ 95.1203
Permissible communications.
(a) Except for the purposes of testing
and for demonstrations to health care
professionals, MedRadio programmer/
control transmitters may transmit only
non-voice data containing operational,
diagnostic and therapeutic information
associated with a medical implant
device or medical body-worn device
that has been implanted or placed on
the person by or under the direction of
a duly authorized health care
professional.
(b) Except as provided in § 95.628(b)
no MedRadio implant or body-worn
transmitter shall transmit except in
response to a transmission from a
MedRadio programmer/control
transmitter or in response to a non-radio
frequency actuation signal generated by
a device external to the body with
respect to which the MedRadio implant
or body-worn transmitter is used.
(c) MedRadio programmer/control
transmitters may be interconnected with
other telecommunications systems
including the public switched telephone
network.
(d) For the purpose of facilitating
MedRadio system operation during a
MedRadio communications session, as
defined in § 95.628, MedRadio
transmitters may transmit in accordance
with the provisions of § 95.628(a) for no
more than 5 seconds without the
communications of data; MedRadio
transmitters may transmit in accordance
with the provisions of § 95.628(b)(3) for
no more than 3.6 seconds in total within
a one-hour time period without the
communications of data; MedRadio
transmitters may transmit in accordance
with the provisions of § 95.628(b)(2) for
no more than 360 milliseconds in total
within a one-hour time period without
the communications of data.
(e) MedRadio programmer/control
transmitters may not be used to relay
information to a receiver that is not
PO 00000
Frm 00071
Fmt 4700
Sfmt 4700
22709
included with a medical implant or
medical body-worn device. Wireless
retransmission of information intended
to be transmitted by a MedRadio
programmer/control transmitter or
information received from a medical
implant or medical body-worn
transmitter shall be performed using
other radio services that operate in
spectrum outside of the MedRadio band.
§ 95.1211
Channel use policy.
(a) The channels authorized for
MedRadio operation by this part of the
FCC Rules are available on a shared
basis only and will not be assigned for
the exclusive use of any entity.
(b) To reduce interference and make
the most effective use of the authorized
facilities, MedRadio transmitters must
share the spectrum in accordance with
§ 95.628.
(c) MedRadio operation is subject to
the condition that no harmful
interference is caused to stations
operating in the 400.150–406.000 MHz
band in the Meteorological Aids,
Meteorological Satellite, or Earth
Exploration Satellite Services.
MedRadio stations must accept any
interference from stations operating in
the 400.150–406.000 MHz band in the
Meteorological Aids, Meterological
Satellite, or Earth Exploration Satellite
Services.
§ 95.1213
Antennas.
No antenna for a MedRadio
transmitter shall be configured for
permanent outdoor use. In addition, any
MedRadio antenna used outdoors shall
not be affixed to any structure for which
the height to the tip of the antenna will
exceed three (3) meters (9.8 feet) above
ground.
§ 95.1215
Disclosure policies.
Manufacturers of MedRadio
transmitters must include with each
transmitting device the following
statement:
‘‘This transmitter is authorized by
rule under the Medical Device
Radiocommunication Service (in part 95
of the FCC Rules) and must not cause
harmful interference to stations
operating in the 400.150–406.000 MHz
band in the Meteorological Aids (i.e.,
transmitters and receivers used to
communicate weather data), the
Meteorological Satellite, or the Earth
Exploration Satellite Services and must
accept interference that may be caused
by such stations, including interference
that may cause undesired operation.
This transmitter shall be used only in
accordance with the FCC Rules
governing the Medical Device
Radiocommunication Service. Analog
E:\FR\FM\14MYR1.SGM
14MYR1
22710
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Rules and Regulations
and digital voice communications are
prohibited. Although this transmitter
has been approved by the Federal
Communications Commission, there is
no guarantee that it will not receive
interference or that any particular
transmission from this transmitter will
be free from interference.’’
§ 95.1217
Labeling requirements.
Marketing limitations.
Transmitters intended for operation in
the MedRadio Service may be marketed
and sold only for the permissible
communications described in § 95.1209.
jlentini on PROD1PC65 with RULES
§ 95.1221
RF exposure.
MedRadio medical implant or
medical body-worn transmitters (as
defined in appendix 1 to subpart E of
part 95 of this chapter) are subject to the
radiofrequency radiation exposure
requirements specified in §§ 1.1307 and
2.1093 of this chapter, as appropriate.
Applications for equipment
authorization of implant devices
operating under this section must
contain a finite difference time domain
(FDTD) computational modeling report
showing compliance with these
provisions for fundamental emissions.
The Commission retains the discretion
VerDate Nov<24>2008
18:53 May 13, 2009
Jkt 217001
[FR Doc. E9–11063 Filed 5–13–09; 8:45 am]
BILLING CODE 6712–01–C
FEDERAL COMMUNICATIONS
COMMISSION
47 CFR Part 73
(a) MedRadio programmer/control
transmitters shall be labeled as provided
in part 2 of this chapter and shall bear
the following statement in a
conspicuous location on the device:
‘‘This device may not interfere with
stations operating in the 400.150–
406.000 MHz band in the
Meteorological Aids, Meteorological
Satellite, and Earth Exploration Satellite
Services and must accept any
interference received, including
interference that may cause undesired
operation.’’
The statement may be placed in the
instruction manual for the transmitter
where it is not feasible to place the
statement on the device.
(b) Where a MedRadio programmer/
control transmitter is constructed in two
or more sections connected by wire and
marketed together, the statement
specified in this section is required to be
affixed only to the main control unit.
(c) MedRadio transmitters shall be
identified with a serial number. The
FCC ID number associated with a
medical implant transmitter and the
information required by § 2.925 of this
chapter may be placed in the instruction
manual for the transmitter and on the
shipping container for the transmitter,
in lieu of being placed directly on the
transmitter.
§ 95.1219
to request the submission of specific
absorption rate measurement data.
[DA 09–989; MB Docket No. 09–33; RM–
11521]
Television Broadcasting Services;
Derby, KS
AGENCY: Federal Communications
Commission.
ACTION: Final rule.
SUMMARY: The Commission grants a
petition for rulemaking filed by
Entravision Holdings, LLC, the
permittee of station KDCU–DT, to
substitute DTV channel 31 for posttransition DTV channel 46 at Derby,
Kansas.
DATES: This rule is effective May 14,
2009.
FOR FURTHER INFORMATION CONTACT:
Adrienne Y. Denysyk, Media Bureau,
(202) 418–1600.
SUPPLEMENTARY INFORMATION: This is a
synopsis of the Commission’s Report
and Order, MB Docket No. 09–33,
adopted April 27, 2009, and released
April 30, 2009. The full text of this
document is available for public
inspection and copying during normal
business hours in the FCC’s Reference
Information Center at Portals II, CY–
A257, 445 12th Street, SW.,
Washington, DC 20554. This document
will also be available via ECFS (https://
www.fcc.gov/cgb/ecfs/). (Documents
will be available electronically in ASCII,
Word 97, and/or Adobe Acrobat.) This
document may be purchased from the
Commission’s duplicating contractor,
Best Copy and Printing, Inc., 445 12th
Street, SW., Room CY–B402,
Washington, DC 20554, telephone 1–
800–478–3160 or via e-mail https://
www.BCPIWEB.com. To request this
document in accessible formats
(computer diskettes, large print, audio
recording, and Braille), send an e-mail
to fcc504@fcc.gov or call the
Commission’s Consumer and
Governmental Affairs Bureau at (202)
418–0530 (voice), (202) 418–0432
(TTY). This document does not contain
information collection requirements
subject to the Paperwork Reduction Act
of 1995, Public Law 104–13. In addition,
therefore, it does not contain any
information collection burden ‘‘for
small business concerns with fewer than
PO 00000
Frm 00072
Fmt 4700
Sfmt 4700
25 employees,’’ pursuant to the Small
Business Paperwork Relief Act of 2002,
Public Law 107–198, see 44 U.S.C.
3506(c)(4). Provisions of the Regulatory
Flexibility Act of 1980 do not apply to
this proceeding.
The Commission will send a copy of
this Report and Order in a report to be
sent to Congress and the Government
Accountability Office pursuant to the
Congressional review Act, see 5 U.S.C.
801(a)(1)(A).
List of Subjects in 47 CFR Part 73
Television, Television broadcasting.
For the reasons discussed in the
preamble, the Federal Communications
Commission amends 47 CFR Part 73 as
follows:
■
PART 73—RADIO BROADCAST
SERVICES
1. The authority citation for part 73
continues to read as follows:
■
Authority: 47 U.S.C. 154, 303, 334, 336.
§ 73.622
[Amended]
2. Section 73.622(i), the PostTransition Table of DTV Allotments
under Kansas, is amended by adding
DTV channel 31 and removing DTV
channel 46 at Derby.
■
Federal Communications Commission.
Clay C. Pendarvis,
Associate Chief, Video Division, Media
Bureau.
[FR Doc. E9–11207 Filed 5–13–09; 8:45 am]
BILLING CODE 6712–01–P
DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric
Administration
50 CFR Part 622
[Docket No. 040205043–4043–01]
RIN 0648–XP20
Fisheries of the Caribbean, Gulf of
Mexico, and South Atlantic; Snappergrouper Fishery of the South Atlantic;
Closure of the 2009 Commercial
Fishery for Black Sea Bass in the
South Atlantic
AGENCY: National Marine Fisheries
Service (NMFS), National Oceanic and
Atmospheric Administration (NOAA),
Commerce.
ACTION: Temporary rule; closure.
SUMMARY: NMFS closes the commercial
fishery for black sea bass in the
exclusive economic zone (EEZ) of the
South Atlantic. NMFS has determined
that the quota for the commercial
E:\FR\FM\14MYR1.SGM
14MYR1
Agencies
[Federal Register Volume 74, Number 92 (Thursday, May 14, 2009)]
[Rules and Regulations]
[Pages 22696-22710]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11063]
=======================================================================
-----------------------------------------------------------------------
FEDERAL COMMUNICATIONS COMMISSION
47 CFR Parts 1, 2 and 95
[ET Docket Nos. 06-135, 05-213 and 03-92, RM-11271; FCC 09-23]
Spectrum Requirements for Advanced Medical Technologies
AGENCY: Federal Communications Commission.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This document establishes a new Medical Device
Radiocommunication Service (MedRadio Service) of the Commission's
rules. This new service incorporates the existing Medical Implant
Communications Service (MICS) ``core'' band at 402-405 MHz, and also
includes two megahertz of newly designated spectrum in the adjacent
``wing'' bands at 401-402 MHz and 405-406 MHz. The MedRadio Service
will accommodate the operation of body-worn as well as implanted
medical devices, including those using either listen-before-talk
(``LBT'') frequency monitoring or non-LBT spectrum access methods, in
designated portions of the 401-406 MHz band.
DATES: Effective August 12, 2009.
FOR FURTHER INFORMATION CONTACT: Gary Thayer, (202) 418-2290, e-mail
Gary.Thayer@fcc.gov.
SUPPLEMENTARY INFORMATION: This is a summary of the Commission's Report
and Order, ET Docket Nos. 06-135, 05-213, and 03-92, RM-11271, FCC 09-
23, adopted March 19, 2009, and released March 20, 2009. The full text
of this document is available on the Commission's Internet site at
https://www.fcc.gov. It is also available for inspection and copying
during regular business hours in the FCC Reference Center (Room CY-
A257), 445 12th St., SW., Washington, DC 20554. The full text of this
document also may be purchased from the Commission's duplication
contractor, Best Copy and Printing Inc., Portals II, 445 12th St., SW.,
Room CY-B402, Washington, DC 20554; telephone (202) 488-5300; fax (202)
488-5563; e-mail FCC@BCPIWEB.COM.
[[Page 22697]]
Summary of the Report and Order
1. Overview. In July 2006, the Commission adopted a Notice of
Proposed Rulemaking (NPRM), Notice of Inquiry (NOI) and Order--
collectively, the MedRadio NPRM. In the MedRadio NPRM, the Commission
proposed to establish a new service for medical radiocommunication
devices to better accommodate the varieties of new implantable and
body-worn medical devices.
2. In this Report and Order, the Commission decided to establish a
new Medical Device Radio-communication Service (MedRadio Service) under
part 95 of the Commission's rules. Under the rules adopted by the
Commission in this Report and Order, this new service incorporates the
existing Medical Implant Communications Service (MICS) ``core'' band at
402-405 MHz, and also includes two megahertz of newly designated
spectrum in the adjacent ``wing'' bands at 401-402 MHz and 405-406 MHz.
Thus, the MedRadio Service will provide a total of five megahertz of
contiguous spectrum on a secondary basis and non-interference basis for
advanced wireless medical radiocommunication devices used for
diagnostic and therapeutic purposes in humans. In addition, the
MedRadio Service will accommodate the operation of body-worn as well as
implanted medical devices, including those using either listen-before-
talk (``LBT'') frequency monitoring or non-LBT spectrum access methods,
in designated portions of the 401-406 MHz band.
3. The Commission found that the new MedRadio spectrum in the 401-
402 MHz and 405-406 MHz wing bands is well suited for use on a
secondary basis by the medical implant and body-worn devices covered by
this Order for several reasons. First, these frequencies offer the same
propagation, availability, and compatibility characteristics that were
found to be favorable for the MICS in the 402-405 MHz core band. In
addition, this new designation will result in a continuous span of
spectrum (from 401-406 MHz) that matches the five-megahertz of spectrum
that is also designated internationally for similar use by medical
implant and body-worn devices.
4. The Commission noted that the service and technical rules
adopted in this Report and Order for the MedRadio Service are based
upon the existing MICS rules, and include modified spectrum sharing
requirements in the new wing bands. The new rules will permit the use
of both medical implant devices and medical body-worn devices in
specified segments of the 401-406 MHz band.
5. The Commission found that these new MedRadio sharing rules will
provide a greater degree of flexibility than is permitted by the
existing medical implant rules, while also assuring spectrum use
compatibility among different device types. The Commission further
found that the new designation in the wing bands will provide the
additional shared spectrum that is urgently needed for operation of
both implant and body-worn devices. The Commission stated its further
belief that the MedRadio rules adopted in this Order should encourage
the continuing use of the legacy MICS core band predominantly for life-
critical applications, such as those served by the existing population
of medical implant devices presently used.
6. With respect to the potential for interference to incumbent
users of the 401-402 MHz and 405-406 MHz wing bands arising from the
operation of MedRadio devices, the Commission concluded that the
potential for such interference is negligibly small. The Commission
noted that, in the United States, the 401-406 MHz band is allocated for
various Federal and non-Federal uses on a primary basis, and the 402-
405 MHz band is allocated for mobile, except mobile aeronautical,
service on a secondary basis, with use limited to MICS. The Commission
determined that, given the ultra low power limits and intermittent
operating modes that will be used by these medical devices, and the
expectation of large separation distances, there is little likelihood
that these medical devices could cause harmful interference to
incumbent operations.
7. With respect to the potential for harmful effects to MedRadio
devices due to received interference from incumbent users, the
Commission observed that it would be beneficial if MedRadio devices
employed robust designs. For example, the Commission noted that
MedRadio medical devices--particularly those devices used for life
critical and time-sensitive applications--might need to employ a
variety of error detection and correction techniques, frequency
monitoring capabilities, and re-transmission protocols.
8. In broader terms, the Commission determined that the additional
spectrum and enhanced flexibility afforded in the new rules will
promote the accelerated development of newer generations of advanced
medical device technologies. These advances, the Commission found, will
herald dramatic improvements in therapeutic/diagnostic patient care and
quality of life for countless individuals. The Commission also noted
that the MedRadio designation and rules adopted in this Order are
harmonized for the most part in their general approach with similar
European Telecommunication Standards Institute (ETSI) standards
relating to use of the 401-406 MHz band by medical implant and body-
worn devices in other regions of the world. The Commission stated its
belief that such harmonization will serve the public interest by
offering Americans greater confidence of reliable device operation
while traveling abroad, and conversely, by offering similar confidence
for foreign visitors to the United States. The Commission also
determined that economies of scale resulting from harmonized rules for
domestic manufacturers seeking to compete in the world market should
foster a reduction of device prices, thus making the benefits of such
technologies more widely available and affordable for the American
public.
9. Licensing. Consistent with the existing MICS licensing scheme,
the Commission decided that the new MedRadio service at 401-406 MHz
will be governed under Part 95 of the Commission's rules, thus
providing for license-by-rule operation throughout the 5 megahertz
band. The Commission concluded that this approach minimizes regulatory
procedures and will facilitate the more expeditious deployment of new
generations of beneficial wireless medical devices in these bands that
can improve the quality of life for countless Americans, thus serving
the public interest, convenience and necessity. The Commission also
decided that the operation of medical devices in the MedRadio band will
be on a secondary, non-interference basis with respect to other
authorized services and as such they must accept harmful interference
from the systems operating in those services. MedRadio devices will
operate on a shared, non-exclusive basis with respect to each other.
10. Definitions--Implant and Body-worn Devices. In order to be
deemed a medical body-worn device or medical body-worn transmitter, the
Commission required that the antenna of the associated patient-worn
device be placed upon or in very close proximity (e.g., within a few
centimeters) to the body. In order to be classified as a medical
implant transmitter or medical implant device, the Commission required
that the transmitting antenna of the patient device must itself be
implanted wholly within the body--which would include any point below
the skin, or more deeply within the body. The Commission retained the
[[Page 22698]]
existing definitions for medical implant devices.
11. Authorized Frequencies for Implant and Body-Worn Devices. The
Commission concluded that implanted devices will be permitted in both
the existing MICS core band at 402-405 MHz, as well as in the wing
bands at 401-402 MHz and 405-406 MHz. This will allow medical implant
devices to operate anywhere in the 401-406 MHz band--but subject to
different technical requirements in the core and wing bands.
12. The Commission decided, with one exception, to permit body-worn
devices to operate only in the wing bands at 401-402 MHz and 405-406
MHz. Thus, in the new MedRadio wing bands, both implant and body-worn
devices will be allowed to operate--under common technical requirements
for each--throughout both the 401-402 MHz and 405-406 MHz frequency
range. The Commission stated its belief this approach will serve to
accommodate a greater variety of implant and body-worn devices. The
Commission also observed that, by preserving the core band at 402-405
MHz primarily for communications involving deeply implanted devices,
these frequencies would likely continue to be used largely for life-
critical medical devices such as cardiac defibrillators.
13. As an exception to the general rule for body-worn devices, the
Commission decided to permit the operation in the core band of
temporary body-worn devices that are used to evaluate the efficacy of
an implanted medical device.
14. The Commission determined that allowing the operation of such
temporary body-worn devices will enhance the therapeutic and diagnostic
options available to patients. In particular, the Commission noted that
this will allow physicians to better evaluate the efficacy of proposed
treatments involving implanted devices prior to actual device
implantation. The Commission decided to permit the operation of such
temporary body-worn devices on any frequency in the 402-405 MHz core
band provided that: (1) Such external operation is limited solely to
evaluating with a patient the efficacy of a fully implanted permanent
medical device that is intended to replace the temporary body-worn
device; (2) RF transmissions from the external device must cease
following the patient evaluation period, which may not exceed 30 days,
except where a health care practitioner determines that additional time
is necessary due to unforeseen circumstances; (3) the maximum output
power of the external, temporary body-worn device shall not exceed 200
nW EIRP; and (4) the external device must comply fully with all other
MedRadio rules described throughout the core 402-405 MHz band.
15. The Commission declined to explicitly limit the core band to
life-critical and time-sensitive applications, or to designate the wing
bands for non-life-critical, non-time sensitive applications. The
Commission said that its decision to limit the core band primarily to
communications involving implanted devices, coupled with the technical
rules adopted for use of the core and wing bands will achieve much the
same result, while providing greater flexibility for device
manufacturers and practitioners. The Commission determined that leaving
the ultimate decision on these matters to health care professionals and
medical device manufactures, in concert with FDA-required risk
management processes, would result in better and more flexible use of
this scarce spectrum resource.
16. Permissible Communications and Operator Eligibility. The
Commission concluded that the new MedRadio service will be governed by
the same operator eligibility and permissible communications
requirements that pertain to the legacy MICS. According to the
Commission, this will result in a more beneficial use of the spectrum
than alternative approaches.
17. More specifically, the Commission decided that MedRadio devices
may be used only by persons for diagnostic and therapeutic purposes,
and only when provided for such purposes to a human patient under the
direction of a duly authorized health care professional. Furthermore,
the Commission limited the MedRadio service to the transmission of non-
voice data. MedRadio programmer/control transmitters may not relay
information on MedRadio frequencies to a receiver that is not included
with a MedRadio device. The Commission concluded that these
requirements are central to maintaining the originally intended
character and utility of this spectrum, which the Commission found has
proven to be of significant benefit to many patients over the years.
18. The Commission declined to adopt rules in this Order that would
permit the operation of wireless hearing aids in the upper portion of
the lower MedRadio wing band. However, in recognition of the important
public interest benefits associated with this proposal, the Commission
welcomed additional technical submissions or revisions to address
whether this or some other band(s) could accommodate various types of
hearing aid devices, and stated that it would consider developing a
record through a notice of proposed rulemaking to more fully analyze
these matters.
19. The Commission also declined to allow the use of MedRadio
devices in connection with animal test subjects in the course of human
drug research. The Commission found that such testing would not, in and
of itself, directly perform any diagnostic or therapeutic function for
a human patient. In contrast, the Commission observed that, since its
creation, the legacy MICS had been explicitly reserved for use by
devices performing diagnostic and therapeutic functions with human
patients and only when such use has been duly authorized by a health
care professional. It further found that changing the eligibility
requirements to permit animal test subject use would constitute a major
departure from these underlying requirements and that such a departure
did not appear to be warranted based upon the record in this
proceeding. From a procedural perspective, the Commission further
stated that the MedRadio NPRM neither proposed, nor sought comment on,
modifying these basic service and eligibility provisions; and that it
particularly did not address the specific question at issue here of
whether use of the MICS/MedRadio frequencies should be extended to
animal testing. Thus, the Commission concluded that it had an
insufficient substantive record or procedural notice upon which to
pursue the matter of animal test subjects.
20. MedRadio channels. The Commission decided to generally carry
forward the MICS rules into the new MedRadio Service. Under the
existing rules, no particular channeling scheme is specified for the
operation of MICS devices. Instead, a ``channel'' is simply defined as
any continuous segment of spectrum used by a medical device. Thus, a
MedRadio device may transmit on any center frequency so long as the
maximum authorized emission bandwidth is not exceeded. The Commission
stated its belief that this approach is beneficial because it would
continue to provide the greater flexibility that device manufacturers
now use as compared with a rigid channeling scheme.
21. Emission Bandwidth. With respect to the new MedRadio wing bands
at 401-402 MHz and 405-406 MHz, the Commission concluded that a 100
kilohertz maximum authorized emission bandwidth in the limited space of
the one-megahertz wide wing bands will foster more intensive spectrum
utilization by a greater number of devices as compared with a 300
[[Page 22699]]
kilohertz maximum bandwidth. The Commission determined that this
smaller bandwidth would allow more devices to use the wing bands on
non-overlapping spectrum. In addition, the Commission found that this
bandwidth will also serve to minimize interference potential from other
MedRadio devices, particularly in light of the fact that both LBT and
non-LBT devices will share the entire wing bands.
22. As one exception to the general bandwidth requirement for the
wing bands, the Commission decided to allow up to a 150 kilohertz
maximum authorized emission bandwidth at 401.85-402 MHz. In reaching
this decision, the Commission recognized that some body worn devices,
such as the glucose monitoring devices that are now operating in the
core band under a waiver, need a slightly wider emission bandwidth.
Thus, the Commission found that its decision here to allow a slightly
wider emission bandwidth at the upper edge of the 401-402 MHz wing band
will facilitate transitioning such devices now operating under rule
waivers out of the core band. In addition, the Commission observed that
the narrower bandwidth for the wing bands, is expected to be better
suited for non-life-critical devices--namely, those with less severe
battery life constraints that are tailored for operation with lower
bandwidth data streams utilizing a relatively greater number of longer
data transmission sessions as compared with devices used in the core
band.
23. For the core band at 402-405 MHz, the Commission decided to
maintain the existing maximum authorized emission bandwidth of 300
kilohertz. The Commission found that, relative to the 100 kilohertz
bandwidth it adopted for the wing bands, this 300 kilohertz bandwidth
will better facilitate more data-intensive transmissions of shorter
duration which tend to be more energy efficient, and thus prolong
battery life for implants. This will also support higher data
transmission rates than could be accommodated by the maximum authorized
emission bandwidth of 100 kilohertz channels of the wing bands, and
thus may be more desirable for certain applications. The Commission
found that such characteristics are especially beneficial in extending
the battery life of deep implant devices.
24. The Commission decided that it would continue to permit
MedRadio transmitters to utilize full duplex or half duplex
communications if the total amount of bandwidth used by all of the
MedRadio channels employed by a MedRadio device during a MedRadio
communications session does not exceed the maximum authorized emission
bandwidth (i.e., 100 kilohertz in the wing bands and 300 kilohertz in
the core band). Moreover, smaller bandwidths may be employed by a
single MedRadio device so long as the device adheres to all other EIRP
and unwanted emission limits. For example, a single MedRadio device
operating in the wing bands could be designed to operate nominally on
two channels, each having a maximum emission bandwidth of 50 kilohertz,
because the communications session would, in aggregate, be 100
kilohertz. The Commission noted that, in essence, these provisions
carry forward the existing channel use provisions of the MICS rules
into the new MedRadio rules.
25. Frequency monitoring requirement. In the Report and Order, the
Commission observed the current MICS rules require that the programmer/
control transmitter associated with a medical implant device in the
402-405 MHz band must incorporate a frequency monitoring mechanism to
monitor the channel or channels that the medical device transmitters
intend to occupy. The Commission further stated its belief that an LBT
frequency monitoring requirement is beneficial because it facilitates
spectrum sharing among many uncoordinated devices and can reduce the
likelihood of harmful interference from federal systems that are
allocated on a primary basis. Thus, the Commission decided to maintain
the current frequency monitoring protocol specified in the form MICS
rules as a general requirement for implant devices permitted throughout
the entire 401-406 MHz MedRadio core band, as well as for body-worn
devices permitted in the new wing bands. In addition, the Commission
also extended the ``medical implant event'' exception of the current
rules to LBT-enabled implant devices operating throughout the 401-406
MHz MedRadio band.
26. In further recognition of the potential advantages of non-LBT
spectrum access methods for certain low power, low duty cycle (LP-LDC)
devices--particularly, in terms of extended battery life, reduced
complexity, and lower device cost to patients--the Commission decided
to permit the use of non-LBT spectrum access methods in the wing bands,
with certain transmitter power and duty cycle limits, by both implant
and body-worn devices. In addition, the Commission permitted the use of
non-LBT spectrum access methods for implant devices that operate with
an emission bandwidth not exceeding 300 kilohertz centered at 403.65
MHz in the existing core band with certain transmitter power and duty
cycle limits. Finally, the Commission also decided to permit the
operation on any of the frequencies in the 402-405 MHz band of
temporary body-worn transmitting devices that are used solely during a
limited patient evaluation period in order to determine the suitability
of a fully implanted device, provided that they fully comply with all
other MedRadio rules applicable to the band.
27. Transmitter power and duty cycle. The Commission limited the
maximum EIRP of LBT-enabled implant devices throughout the 401-406 MHz
band and LBT-enabled body-worn medical devices in the wing bands to 25
microwatts EIRP. The Commission determined that, as with the original
MICS rules, this limit is intended to ensure efficient spectrum sharing
and compatibility among multiple uncoordinated devices. Furthermore,
the 25 microwatt limit will maintain continuity with the present EIRP
limit and LBT frequency monitoring requirement for the core band (which
we also maintain under the new MedRadio rules) that has served well for
spectrum access.
28. With respect to access to the 402-405 MHz band by non-LBT
devices, the Commission found that the convergence of comments in the
record, particularly subsequent to the adoption by ETSI of similar
standards, supported permitting operation by such devices with a total
emission bandwidth not exceeding 300 kilohertz, centered at 403.65 MHz,
with a maximum EIRP of 100 nanowatts and with maximum duty-cycle and
transmission session limits of 0.01% and ten per hour, respectively.
The Commission stated that its decision was informed by the
increasingly widespread adoption of standards internationally that
provide for non-LBT spectrum access methods in the 402-405 MHz band.
Furthermore, based upon the Commission's prior experience with single-
channel non-LBT devices operating under rule waivers in the core MICS
band the Commission concluded that these EIRP and duty cycle limits
would be sufficiently conservative to permit efficient spectrum sharing
between LBT enabled and non-LBT devices that choose to operate at
403.65 MHz.
29. For devices using non-LBT spectrum access methods in the new
MedRadio wing bands at 401-402 and 405-406 MHz, the Commission adopted
power and duty cycle limits that match the proposals in the MedRadio
NPRM, namely a maximum EIRP of 250 nanowatts, together with a maximum
[[Page 22700]]
duty cycle limit of 0.1% and a maximum limit of 100 communication
sessions per hour. The Commission stated its belief that permitting the
higher EIRP of 250 nanowatts for non-LBT operation in the wing bands,
as compared with the 100 nanowatts adopted for non-LBT operation in the
core band, will serve to encourage use of the wing bands for the
majority of non-LBT applications.
30. The Commission also recognized that some body worn devices may
require higher power and greater bandwidth, such as the glucose
monitoring devices manufactured by one manufacturer that are now
operating in the core band under a waiver. Thus, the Commission decided
to also allow non-LBT MedRadio devices using a maximum of 25 microwatts
EIRP to operate at 401.85-402 MHz at the upper end of the lower wing
band. The Commission determined that its decision would facilitate the
transition of such devices now operating under waivers out of the core
band, and into the new MedRadio wing bands. The Commission also noted
that permitting the higher power and bandwidth would also provide
flexibility for other manufacturers designing medical devices in these
bands.
31. Unwanted emissions. The Commission retained without
modification the existing in-band and out-of-band emission limits for
the MedRadio core band frequencies at 402-405 MHz. For the new MedRadio
wing bands at 401-402 MHz and 405-406 MHz, the Commission adopted an
emission mask having the same form as the emission mask that already
exists for the core band, but modified to apply over the narrower 100
kilohertz maximum authorized emission bandwidth of the wing band. Thus,
the Commission required that emissions from devices operating within
the MedRadio wing bands more than 50 kilohertz away from the center
frequency of a transmission be attenuated below the actual transmitter
output power by at least 20 dB. In addition, it required emissions 100
kilohertz or less below 401 MHz, or above 406 MHz, to be attenuated
below the maximum permitted output power by at least 20 dB. Finally,
for out-of-band emissions at more than 100 kilohertz outside the 401
MHz and 406 MHz MedRadio band edges, the Commission adopted generally
the same field strength limits on emissions that presently apply to the
core band.
32. The Commission declined to impose more restrictive limits on
emissions from MedRadio wing band devices into the existing core band.
The Commission said that under such an approach, which was recommended
by one commenter, wing band devices would be burdened with more
stringent limits on radiation into the core band as compared to core
band devices. The Commission found no compelling reason to place wing
band devices on such an unequal footing with core band devices,
particularly if such a limit were to be set below the existing general
emission limits contained in Sec. 15.209 as suggested by one
commenter. The Commission stated that it was confident that
manufacturers of wing band devices are capable of designing their
products to be compatible with and to protect core band devices,
especially when both types of devices are used by the same patient. In
addition, the Commission found that the emission limits it adopted
would afford sufficient protection to satellite operations on
frequencies below 401 MHz adjacent to the lower MedRadio wing band.
33. RF safety and EIRP compliance. The Commission retained the
basic requirements in the current rules as they apply RF safety and
EIRP compliance requirements for implanted devices. In addition, the
Commission decided that, to the extent feasible, body-worn MedRadio
devices shall be governed by the same requirements as other hand-held
transmitting devices for the purposes of demonstrating compliance with
RF safety and EIRP limits.
34. The Commission observed that it has another ongoing proceeding
concerning RF exposure that would be better suited to address several
other concerns expressed by some commenters. One issue involves whether
and when open-area test sites or body-torso simulator measurements
should be performed, and whether a 4 dB EIRP correction factor should
be applied between implant and body-worn devices to account for the
absorption of radio energy by body tissue that can be associated with
implanted devices. A second issue involves whether unspecified ``other
techniques'' (beyond the finite difference time domain (FDTD) technique
cited in the existing rules) could be used for equipment authorization
and RF exposure evaluation purposes. In view of the ongoing RF safety
proceeding, the Commission declined to make any further modifications
in this Report and Order.
35. Disposition of Biotronik and DexCom Waivers. The Commission
noted that it had previously granted waivers to two device
manufacturers (Biotronik and DexCom) that permit the manufacture and
marketing in the United States of certain models of cardiac and
diabetic therapy devices that do not possess the LBT frequency
monitoring capability required by the present MICS rules for the core
band at 402-405 MHz. Both waivers were stated to be valid for one year
from the effective date of the final MedRadio rules adopted in this
proceeding.
36. With respect to the Biotronik Waiver, the Commission found that
the technical parameters of the authorized cardiac devices would now be
encompassed within the provisions of the new MedRadio rules adopted
herein--which provide for non-LBT operation by low power, low duty
cycle implants operating between 403.5-403.8 MHz in the 402-405 MHz
core band. Consequently, the Commission found that Biotronik Waiver
would be rendered moot upon the effective date of the MedRadio rules
adopted in this Report and Order.
37. With respect to the DexCom Waiver, the Commission found that
the covered devices did not comply with the new MedRadio rules. It thus
decided to extend the waiver term for four years from the effective
date of the MedRadio rules adopted herein. The Commission stated that
this extended term should provide DexCom with sufficient time to come
into compliance with the new MedRadio rules and to obtain the required
FDA approval. The Commission also found that continued operation of the
DexCom non-LBT devices in the core band, particularly at the higher
power levels they use, could in the long term prove problematic for
other rules-compliant devices--especially those used for life-critical
applications--as the numbers of these types of devices grow. Further,
the Commission also observed that the wing bands provide adequate
spectrum for both LBT and non-LBT body-worn devices and that DexCom's
devices may reasonably be accommodated under the new MedRadio rules for
these bands. In declining to extend the waiver for 5 years as requested
by DexCom, the Commission stated that it was not persuaded that the
relatively small move in operating frequency, while maintaining
emission bandwidth, power and duty cycle specifications, would require
5 additional years. Thus, the Commission encouraged DexCom to
transition to the newly designated spectrum as soon as practicable.
[[Page 22701]]
Final Regulatory Flexibility Analysis
38. As required by the Regulatory Flexibility Act (RFA),\1\ an
Initial Regulatory Flexibility Analysis (IFRA) was incorporated in the
Notice of Proposed Rulemaking and Notice of Inquiry and Order (MedRadio
NPRM) in ET Docket No. 06-135.\2\ The Commission sought written public
comment on the proposals in the MedRadio NPRM, including comment on the
IRFA. This present Final Regulatory Flexibility Analysis (FRFA)
conforms to the RFA.
---------------------------------------------------------------------------
\1\ See 5 U.S.C. 603. The RFA, see 5 U.S.C. 601-612, has been
amended by the Small Business Regulatory Enforcement Fairness Act of
1966 (SBREFA), Public Law 104-121, Title II, 110 Stat. 857 (1996).
\2\ Investigation of the Spectrum Requirements for Advanced
Medical Technologies, Amendment of Parts 2 and 95 of the
Commission's Rules to Establish the Medical Device Radio
Communications Service at 401-402 and 405-406 MHz, DexCom, Inc.
Request for Waiver of the Frequency Monitoring Requirements of the
Medical Implant Communications Service Rules, Biotronik, Inc.
Request for Waiver of the Frequency Monitoring Requirements for the
Medical Implant Communications Service Rules, ET Docket No. 06-135,
RM-11271, Notice of Proposed Rulemaking and Notice of Inquiry and
Order, 21 FCC Rcd 8164 (2006).
---------------------------------------------------------------------------
A. Need for and Objectives, of the Report and Order
39. The Report and Order establishes the Medical Device
Radiocommunication Service (MedRadio) under part 95 of the Commission's
rules. This new service will incorporate the existing Medical Implant
Communications Service (MICS) ``core'' band at 402-405 MHz, and include
two megahertz of newly designated spectrum in the adjacent ``wing''
bands at 401-402 MHz and 405-406 MHz. Altogether, the MedRadio Service
will provide a total of five megahertz of contiguous spectrum for
advanced wireless medical radiocommunication devices to be used for
diagnostic and therapeutic purposes in humans. Among other benefits,
the MedRadio Service will accommodate the operation of body-worn as
well as implanted medical devices, including those using either LBT or
non-LBT spectrum access methods, in designated portions of the 401-406
MHz band.
40. Significant advances in wireless implanted and body-worn
medical technologies are revolutionizing treatment for a wide variety
of medical conditions and, even more fundamentally, creating new health
care models serving to improve quality of life for all Americans. As
demonstrated by the comment record in this proceeding, implanted and
body-worn medical devices that rely upon wireless technologies are
being used even today to treat a variety of cardiac and diabetic
conditions. For example, wireless implanted cardiac devices serve as
defibrillators and pacemakers without the need for external wired
connections; while other radio-equipped devices, such as blood glucose
monitors and insulin pumps, support more timely treatment for diabetic
patients and allow physicians to wirelessly retrieve data and then make
operating parameter adjustments with greater ease and accuracy than
with the more traditional wired connection technologies. Some examples
of newer generations of devices that could benefit from the use of
wireless technologies include implanted vagus nerve stimulators that
send electric pulses to the brain to treat severe chronic depression,
and deep brain stimulators used to treat tremors related to Parkinson's
disease.\3\ Such advances have the potential to significantly improve
the quality of life and sophistication of therapy for countless
Americans living with a variety of medical conditions; and, in turn,
could result in lower medical costs and extend the time between
hospital visits and surgical procedures.
---------------------------------------------------------------------------
\3\ Id.
---------------------------------------------------------------------------
B. Summary of Significant Issues Raised by Public Comments in Response
to the IRFA
41. There were no comments filed that specifically addressed the
rules and policies proposed in the IFRA.
C. Description and Estimate of the Number of Small Entities to Which
the Rules Will Apply
42. The RFA directs agencies to provide a description of and, where
feasible, an estimate of the number of small entities that may be
affected by the proposed rules, if adopted.\4\ The RFA generally
defines the term ``small entity'' as having the same meaning as the
terms ``small business,'' ``small organization,'' and ``small
governmental jurisdiction.'' \5\ In addition, the term ``small
business'' has the same meaning as the term ``small business concern''
under the Small Business Act.\6\ A small business concern is one which:
(1) Is independently owned and operated; (2) is not dominant in its
field of operation; and (3) satisfies any additional criteria
established by the SBA.\7\
---------------------------------------------------------------------------
\4\ 5 U.S.C. 603(b)(3).
\5\ 5 U.S.C. 601(6).
\6\ 5 U.S.C. 601(3) (incorporating by reference the definition
of ``small business concern'' in 15 U.S.C. 632). Pursuant to the
RFA, the statutory definition of a small business applies ``unless
an agency, after consultation with the Office of Advocacy of the
Small Business Administration and after opportunity for public
comment, establishes one or more definitions of such term which are
appropriate to the activities of the agency and publishes such
definition(s) in the Federal Register.'' 5 U.S.C. 601(3).
\7\ Small Business Act, 15 U.S.C. 632 (1996).
---------------------------------------------------------------------------
43. Nationwide, there are a total of approximately 22.4 million
small businesses, according to SBA data.\8\ A ``small organization'' is
generally ``any not-for-profit enterprise which is independently owned
and operated and is not dominant in its field.'' \9\ Nationwide, as of
2002, there were approximately 1.6 million small organizations.\10\ The
term ``small governmental jurisdiction'' is defined generally as
``governments of cities, towns, townships, villages, school districts,
or special districts, with a population of less than fifty thousand.''
\11\ Census Bureau data for 2002 indicate that there were 87,525 local
governmental jurisdictions in the United States.\12\ We estimate that,
of this total, 84,377 entities were ``small governmental
jurisdictions.'' \13\ Thus, we estimate that most governmental
jurisdictions are small.
---------------------------------------------------------------------------
\8\ See SBA, Programs and Services, SBA Pamphlet No. CO-0028, at
page 40 (July 2002).
\9\ 5 U.S.C. 601(4).
\10\ Independent Sector, The New Nonprofit Almanac & Desk
Reference (2002).
\11\ 5 U.S.C. 601(5).
\12\ U.S. Census Bureau, Statistical Abstract of the United
States: 2006, Section 8, page 272, Table 415.
\13\ We assume that the villages, school districts, and special
districts are small, and total 48,558. See U.S. Census Bureau,
Statistical Abstract of the United States: 2006, section 8, page
273, Table 417. For 2002, Census Bureau data indicate that the total
number of county, municipal, and township governments nationwide was
38,967, of which 35,819 were small. Id.
---------------------------------------------------------------------------
44. Personal Radio Services. The Medical Device Radio
Communications Service are being placed within part 95 of our rules
(``Personal Radio Services''). Personal radio services provide short-
range, low power radio for personal communications, radio signaling,
and business communications not provided for in other services. The
Personal Radio Services include spectrum licensed under part 95 of our
rules and covers a broad range of uses.\14\ Many of the licensees in
these services are individuals, and thus are not small entities. In
addition, due to the fact that licensing of operation under part 95 is
accomplished by rule (rather than by issuance of individual license),
and due to the shared nature of the spectrum utilized by some of these
services, the Commission lacks direct information other than the census
data above, upon which to base an estimation of the number of small
entities under an SBA
[[Page 22702]]
definition that might be directly affected by the proposed rules.
---------------------------------------------------------------------------
\14\ 47 CFR part 90.
---------------------------------------------------------------------------
45. The Commission notes, however, that the designation for the two
megahertz of spectrum for the Medical Device Radio Communications
Service would be limited to use by medical implant and body-worn
medical devices and, thus, would not be shared with other non-Federal
Governmental uses. To date, there are only a small number of
manufacturers (i.e., less than ten--as few as five) that produce these
devices, and FDA approval must be secured before such devices are
brought to market. Due to the stringent FDA approval requirements, the
small number of existing medical device manufacturers tends to focus
very narrowly on this highly specialized market niche.
46. Wireless Communications Equipment Manufacturers. The Census
Bureau does not have a category specific to medical device
radiocommunication manufacturing. The appropriate category is that for
wireless communications equipment manufacturers. The Census Bureau
defines this category as follows: ``This industry comprises
establishments primarily engaged in manufacturing radio and television
broadcast and wireless communications equipment. Examples of products
made by these establishments are: transmitting and receiving antennas,
cable television equipment, GPS equipment, pagers, cellular phones,
mobile communications equipment, and radio and television studio and
broadcasting equipment.'' The SBA has developed a small business size
standard for Radio and Television Broadcasting and Wireless
Communications Equipment Manufacturing, which is: all such firms having
750 or fewer employees.\15\ According to Census Bureau data for 2002,
there were a total of 1,041 establishments in this category that
operated for the entire year. Of this total, 1,010 had employment of
under 500, and an additional 13 had employment of 500 to 999. Thus,
under this size standard, the majority of firms can be considered
small.\16\
---------------------------------------------------------------------------
\15\ NAICS code 334220.
\16\ NAICS code 11210.
---------------------------------------------------------------------------
47. Wireless Service Providers. The SBA has developed a small
business size standard for wireless firms within the two broad economic
census categories of ``Paging'' \17\ and ``Cellular and Other Wireless
Telecommunications.'' \18\ Under both categories, the SBA deems a
wireless business to be small if it has 1,500 or fewer employees. For
the census category of Paging, Census Bureau data for 2002 show that
there were 807 firms in this category that operated for the entire
year. \19\ Of this total, 804 firms had employment of 999 or fewer
employees, and three firms had employment of 1,000 employees or
more.\20\ Thus, under this category and associated small business size
standard, the majority of firms can be considered small. For the census
category of Cellular and Other Wireless Telecommunications, Census
Bureau data for 2002 show that there were 1,397 firms in this category
that operated for the entire year.\21\ Of this total, 1,378 firms had
employment of 999 or fewer employees, and 19 firms had employment of
1,000 employees or more.\22\ Thus, under this second category and size
standard, the majority of firms can, again, be considered small.
---------------------------------------------------------------------------
\17\ 13 CFR 121.201, NAICS code 517211.
\18\ 13 CFR 121.201, NAICS code 517212.
\19\ U.S. Census Bureau, 2002 Economic Census, Subject Series:
``Information,'' Table 5, Employment Size of Firms for the United
States: 2002, NAICS code 517211 (issued Nov. 2005).
\20\ Id. The census data do not provide a more precise estimate
of the number of firms that have employment of 1,500 or fewer
employees; the largest category provided is for firms with ``1000
employees or more.''
\21\ U.S. Census Bureau, 2002 Economic Census, Subject Series:
``Information,'' Table 5, Employment Size of Firms for the United
States: 2002, NAICS code 517212 (issued Nov. 2005).
\22\ Id. The census data do not provide a more precise estimate
of the number of firms that have employment of 1,500 or fewer
employees; the largest category provided is for firms with ``1000
employees or more.''
---------------------------------------------------------------------------
48. Public Safety Radio Services. Public Safety radio services
include police, fire, local government, forestry conservation, highway
maintenance, and emergency medical services.\23\ For small businesses
in this category, the above small business size standard applies to
1500 or fewer employees. There are a total of approximately 127,540
licensees in these services. Governmental entities \24\ as well as
private businesses comprise the licensees for these services. All
governmental entities with populations of less than 50,000 fall within
the definition of a small entity.\25\
---------------------------------------------------------------------------
\23\ With the exception of the special emergency service, these
services are governed by Subpart B of part 90 of the Commission's
Rules, 47 CFR 90.15-90.27. The police service includes approximately
27,000 licensees that serve state, county, and municipal enforcement
through telephony (voice), telegraphy (code) and teletype and
facsimile (printed material). The fire radio service includes
approximately 23,000 licensees comprised of private volunteer or
professional fire companies as well as units under governmental
control. The local government service that is presently comprised of
approximately 41,000 licensees that are state, county, or municipal
entities that use the radio for official purposes not covered by
other public safety services. There are approximately 7,000
licensees within the forestry service which is comprised of
licensees from state departments of conservation and private forest
organizations who set up communications networks among fire lookout
towers and ground crews. The approximately 9,000 state and local
governments are licensed to highway maintenance service provide
emergency and routine communications to aid other public safety
services to keep main roads safe for vehicular traffic. The
approximately 1,000 licensees in the Emergency Medical Radio Service
(EMRS) use the 39 channels allocated to this service for emergency
medical service communications related to the delivery of emergency
medical treatment. 47 CFR 90.15-90.27. The approximately 20,000
licensees in the special emergency service include medical services,
rescue organizations, veterinarians, handicapped persons, disaster
relief organizations, school buses, beach patrols, establishments in
isolated areas, communications standby facilities, and emergency
repair of public communications facilities. 47 CFR 90.33-90.55.
\24\ 47 CFR 1.1162.
\25\ 5 U.S.C. 601(5).
---------------------------------------------------------------------------
D. Description of Projected Reporting, Recordkeeping, and Other
Compliance Requirements for Small Entities
49. The Commission is using the licensing approach for the entire
401-406 MHz MedRadio band that is identical to that used for the
existing MICS band at 402-405 MHz. Thus, rather than require individual
transmitter licensing, the Commission authorizes operation by rule
within the Citizens Band (CB) Radio Service under part 95 of our Rules
and pursuant to Section 307(e) of the Communications Act.\26\ Licensing
will be accomplished through adherence to applicable technical
standards and other operating rules (unlicensed operations). The
Commission concludes that this approach is beneficial because it would
minimize the administrative burden on prospective licensees as compared
with an individual licensing scheme.
---------------------------------------------------------------------------
\26\ See Medtronic Petition at i, 16, and Appendix A, at
proposed Sec. 95.1601. We note that 47 U.S.C. 307(e)(3) provides
that the term ``citizens band radio service'' shall have the meaning
given it by the Commission by rule. 47 U.S.C. 307(e)(1) provides
that upon determination by the Commission that an authorization
serves the public interest, convenience, and necessity, the
Commission may by rule authorize the operation of radio stations
without individual licenses in the citizens band radio service.
---------------------------------------------------------------------------
E. Steps Taken To Minimize the Significant Economic Impact on Small
Entities, and Significant Alternatives Considered
50. The RFA requires an agency to describe any significant
alternatives that it has considered in reaching its proposed approach,
which may include the following four alternatives (among others): (1)
The establishment of differing compliance or reporting requirements or
timetables that take into account the resources available to small
entities; (2) the clarification, consolidation, or simplification of
[[Page 22703]]
compliance or reporting requirements under the rule for small entities;
(3) the use of performance, rather than design, standards; and (4) an
exemption from coverage of the rule, or any part thereof, for small
entities.\27\
---------------------------------------------------------------------------
\27\ See 5 U.S.C. 603(c).
---------------------------------------------------------------------------
51. In the Report and Order the Commission established a new
Medical Device Radiocommunication Service (MedRadio Service) under part
95, which will encompass all medical devices permitted to operate in
the 401-406 MHz band. It sought comment on the options concerning
whether and how the five megahertz of spectrum that would comprise this
MedRadio band could be divided among the evolving varieties of both
implanted and body-worn medical transmitters, including low-power, low-
duty-cycle (LPLDC) devices that do not employ ``listen-before-talk''
(LBT) frequency monitoring spectrum access techniques.
52. Report to Congress: The Commission will send a copy of the
Report and Order, including this FRFA, in a report to be sent to
Congress pursuant to the Congressional Review Act.\28\ In addition, the
Commission will send a copy of the Report and Order, including this
FRFA, to the Chief Counsel for Advocacy of the SBA.
---------------------------------------------------------------------------
\28\ See 5 U.S.C. 801(a)(1)(A).
---------------------------------------------------------------------------
Ordering Clauses
53. Pursuant to the authority contained in Sections 4(i), 301, 302,
303(e), 303(f) and 303(r) of the Communications Act of 1934, as
amended, 47 USC Sections 154(i), 301, 302, 303(e), 303(f) and 303(r),
this Report and Order is adopted and parts 1, 2 and 95 of the
Commission's Rules are amended as set forth in Final Rules effective 90
days after publication in the Federal Register.
54. The Commission grants in part, consistent with the terms of
this order, DexCom, Inc.'s request for extension of waiver, and
otherwise deny the request in all other respects.
55. ET Docket No. 03-92 is terminated.
56. The Commission's Consumer and Governmental Affairs Bureau,
Reference Information Center, shall send a copy of this Report and
Order, including the Final Regulatory Flexibility Analysis in Appendix
C, to the Chief Counsel for Advocacy of the Small Business
Administration.
List of Subjects
47 CFR Part 1
Administrative practice and procedure.
47 CFR Parts 2 and 95
Communications equipment, Radio, Reporting and recordkeeping
requirements.
Federal Communications Commission.
Marlene H. Dortch,
Secretary.
Final Rules
0
For the reasons discussed in the preamble, the Federal Communications
Commission amends 47 CFR parts 1, 2, and 95 to read as follows:
PART 1--PRACTICE AND PROCEDURE
0
1. The authority citation for part 1 continues to read as follows:
Authority: 15 U.S.C. 79 et seq.; 47 U.S.C. 151, 154(i), 154(j),
155, 157, 225, 303(r), and 309.
0
2. Section 1.1307 is amended by revising the fourth sentence in
paragraph (b)(2) to read as follows:
Sec. 1.1307 Actions that may have a significant environmental effect,
for which Environmental Assessments (EAs) must be prepared.
* * * * *
(b) * * *
(2) * * * Equipment authorized for use in the Medical Device
Radiocommunication Service (MedRadio) as a medical implant or body-worn
transmitter (as defined in Appendix 1 to Subpart E of part 95 of this
chapter) is subject to routine environmental evaluation for RF exposure
prior to equipment authorization, as specified in Sec. 2.1093 of this
chapter by finite difference time domain computational modeling or
laboratory measurement techniques. * * *
* * * * *
PART 2--FREQUENCY ALLOCATIONS AND RADIO TREATY MATTERS; GENERAL
RULES AND REGULATIONS
0
3. The authority citation for part 2 continues to read as follows:
Authority: 47 U.S.C. 154, 302a, 303, and 336, unless otherwise
noted.
0
4. Section 2.106, the Table of Frequency Allocations, is amended as
follows:
0
a. Revise page 24.
0
b. In the list of United States (US) footnotes, revise footnote US345.
The revisions read as follows:
Sec. 2.106 Table of Frequency Allocations.
* * * * *
BILLING CODE 6712-01-P
[[Page 22704]]
[GRAPHIC] [TIFF OMITTED] TR14MY09.000
BILLING CODE 6712-01-C
* * * * *
United States (US) Footnotes
* * * * *
US345 In the band 401-406 MHz, the mobile, except aeronautical
mobile, service is allocated on a secondary basis and is limited to,
with the exception of military tactical mobile stations, Medical Device
Radiocommunication Service (MedRadio) operations. MedRadio stations are
authorized by rule on the condition that harmful interference is not
caused to stations in the meteorological aids, meteorological-
satellite, and Earth exploration-satellite services, and that MedRadio
stations accept interference from stations in the meteorological aids,
meteorological-satellite, and Earth exploration-satellite services.
* * * * *
0
5. Section 2.1093 is amended by revising paragraph (c) to read as
follows:
Sec. 2.1093 Radiofrequency radiation exposure evaluation: portable
devices.
* * * * *
(c) Portable devices that operate in the Cellular Radiotelephone
Service, the Personal Communications Service (PCS), the Satellite
Communications Services, the General Wireless Communications Service,
the Wireless Communications Service, the Maritime Services, the
Specialized Mobile Radio Service, the 4.9 GHz Band Service, the
Wireless Medical Telemetry Service (WMTS) and the Medical Device
Radiocommunication Service (MedRadio), authorized under subpart H of
part 22 of this chapter, parts 24, 25, 26, 27, 80 and 90 of this
chapter, subparts H and I of part 95 of this chapter, and unlicensed
personal communication service, unlicensed NII devices and millimeter
wave devices authorized under subparts D and E, 15.253, 15.255 and
15.257 of this chapter are subject to routine environmental evaluation
for RF exposure prior to equipment authorization or use. All other
portable transmitting devices are categorically excluded from routine
environmental evaluation for RF exposure prior to equipment
authorization or use, except as specified in 1.1307(c) and 1.1307(d) of
this chapter. Applications for equipment authorization of portable
transmitting devices subject to routine environmental evaluation must
contain a statement confirming compliance with the limits specified in
paragraph (d) of this section as part of their application. Technical
information showing the basis for this statement must be submitted to
the Commission upon request.
* * * * *
0
6. Section 2.1204 is amended by revising paragraph (a)(9) to read as
follows:
Sec. 2.1204 Import conditions.
(a) * * *
* * * * *
(9) The radio frequency device is a medical implant transmitter
inserted in a person or a medical body-worn transmitter as defined in
part 95, granted entry into the United States or is a control
transmitter associated with such an implanted or body-worn transmitter,
provided, however that the transmitters covered by this provision
otherwise comply with the technical requirements applicable to
transmitters
[[Page 22705]]
authorized to operate in the Medical Device Radiocommunication Service
(MedRadio) under part 95 of this chapter. Such transmitters are
permitted to be imported without the issuance of a grant of equipment
authorization only for the personal use of the person in whom the
medical implant transmitter has been inserted or on whom the medical
body-worn transmitter is applied.
* * * * *
PART 95--PERSONAL RADIO SERVICES
0
7. The authority citation for part 95 continues to read as follows:
Authority: Sections 4, 303, 48 Stat. 1066, 1082, as amended; 47
U.S.C. 154, 303.
0
8. Section 95.401 is amended by revising paragraph (d) to read as
follows:
Sec. 95.401 (CB Rule 1) What are the Citizens Band Radio Services?
* * * * *
(d) The Medical Device Radiocommunication Service (MedRadio)--an
ultra-low power radio service, for the transmission of non-voice data
for the purpose of facilitating diagnostic and/or therapeutic functions
involving implanted and body-worn medical devices. The rules for this
service are contained in subpart I of this part.
* * * * *
0
9. Section 95.601 is amended by revising the last sentence to read as
follows:
Sec. 95.601 Basis and purpose.
* * * The Personal Radio Services are the GMRS (General Mobile
Radio Service)--subpart A, the Family Radio Service (FRS)--subpart B,
the R/C (Radio Control Radio Service)--subpart C, the CB (Citizens Band
Radio Service)--subpart D, the Low Power Radio Service (LPRS)--subpart
G, the Wireless Medical Telemetry Service (WMTS)--subpart H, the
Medical Device Radiocommunication Service (MedRadio)--subpart I, the
Multi-Use Radio Service (MURS)--subpart J, and Dedicated Short-Range
Communications Service On-Board Units (DSRCS-OBUs)--subpart L.
0
10. Section 95.603 is amended by revising paragraph (f) to read as
follows:
Sec. 95.603 Certification required.
* * * * *
(f) Each Medical Device Radiocommunication Service (MedRadio)
transmitter (a transmitter that operates or is intended to operate in
the MedRadio service) must be certificated except for such transmitters
that are not marketed for use in the United States, but which otherwise
comply with the MedRadio Service technical requirements and are
operated in the United States by individuals who have traveled to the
United States from abroad.
* * * * *
0
11. Section 95.605 is revised to read as follows:
Sec. 95.605 Certification procedures.
Any entity may request certification for its transmitter when the
transmitter is used in the GMRS, FRS, R/C, CB, 218-219 MHz Service,
LPRS, MURS, or MedRadio Service following the procedures in part 2 of
this chapter. Dedicated Short-Range Communications Service On-Board
Units (DSRCS-OBUs) must be certified in accordance with subpart L of
this part and subpart J of part 2 of this chapter.
0
12. Section 95.628 is revised to read as follows:
Sec. 95.628 MedRadio transmitters.
(a) Frequency monitoring. Except as provided in (b) of this
section, all MedRadio programmer/control transmitters operating in the
401-406 MHz band must operate under the control of a monitoring system
that incorporates a mechanism for monitoring the channel or channels
that the MedRadio system devices intend to occupy. The monitoring
system antenna shall be the antenna normally used by the programmer/
control transmitter for a communications session. Before the monitoring
system of a MedRadio programmer/control transmitter initiates a
MedRadio communications session, the following access criteria must be
met:
(1) The monitoring system bandwidth measured at its 20 dB down
points must be equal to or greater than the emission bandwidth of the
intended transmission.
(2) Within 5 seconds prior to initiating a communications session,
circuitry associated with a MedRadio programmer/control transmitter
must monitor the channel or channels the system devices intend to
occupy for a minimum of 10 milliseconds per channel.
(3) Based on use of an isotropic monitoring system antenna, the
monitoring threshold power level must not be more than 10logB(Hz) -150
(dBm/Hz) + G(dBi), where B is the emission bandwidth of the MedRadio
communications session transmitter having the widest emission and G is
the MedRadio programmer/control transmitter monitoring system antenna
gain relative to an isotropic antenna. For purposes of showing
compliance with the above provision, the above calculated threshold
power level must be increased or decreased by an amount equal to the
monitoring system antenna gain above or below the gain of an isotropic
antenna, respectively.
(4) If no signal in a MedRadio channel above the monitoring
threshold power level is detected, the MedRadio programmer/control
transmitter may initiate a MedRadio communications session involving
transmissions to and from a medical implant or medical body-worn device
on that channel. The MedRadio communications session may continue as
long as any silent period between consecutive data transmission bursts
does not exceed 5 seconds. If a channel meeting the criteria in
paragraph (a)(3) of this section is unavailable, the channel with the
lowest ambient power level may be accessed.
(5) When a channel is selected prior to a MedRadio communications
session, it is permissible to select an alternate channel for use if
communications are interrupted, provided that the alternate channel
selected is the next best choice using the above criteria. The
alternate channel may be accessed in the event a communications session
is interrupted by interference. The following criteria must be met:
(i) Before transmitting on the alternate channel, the channel must
be monitored for a period of at least 10 milliseconds.
(ii) The detected power level during this 10 millisecond or greater
monitoring period must be no higher than 6dB above the power level
detected when the channel was chosen as the alternate channel.
(iii) In the event that this alternate channel provision is not
used by the MedRadio system or if the criteria in paragraphs (a)(5)(i)
and (ii) are not met, a channel must be selected using the access
criteria specified in paragraphs (a)(1) through (a)(4) of this section.
(6) As used in this section, the following definitions apply:
(i) Emission bandwidth-- Measured as the width of the signal
between the points on either side of carrier center frequency that are
20 dB down relative to the maximum level of the modulated carrier.
Compliance will be determined using instrumentation employing a peak
detector function and a resolution bandwidth approximately equal to 1%
of the emission bandwidth of the device under test.
(ii) MedRadio channel--Any continuous segment of spectrum in the
MedRadio band that is equal to the
[[Page 22706]]
emission bandwidth of the device with the largest bandwidth that is to
participate in a MedRadio communications session.
Note to paragraph (a)(6)(ii): The rules do not specify a channeling
scheme for use by MedRadio systems.
(iii) MedRadio communications session--A collection of
transmissions, that may or may not be continuous, between MedRadio
system devices.
(b) Exceptions to frequency monitoring criteria. MedRadio devices
or communications sessions that meet any one of the following criteria
are not required to use the access criteria set forth in paragraph (a)
of this section:
(1) MedRadio communications sessions initiated by a medical implant
event.
(2) MedRadio devices operating in either the 401-401.85 MHz or 405-
406 MHz bands, provided that the transmit power is not greater than 250
nanowatts EIRP and the duty cycle for such transmissions does not
exceed 0.1%, based on the total transmission time during a one-hour
interval.
(3) MedRadio devices operating in the 401.85-402 MHz band, provided
that the transmit power is not greater than 25 microwatts EIRP and the
duty cycle for such transmissions does not exceed 0.1%, based on the